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Summary 
 
A multicellular organism developes from a one-cell zygote. During  embryonic development, 
highly coordinated gene regulation enables cells to differentiate into various  tissues and cell 
types. These processes are largely mediated by transcription factors (TFs). TFs are DNA binding 
proteins that impact the expression of other genes. This is accomplished by monomer, homo-, 
heterodimer, or through tethered TF-DNA binding. Cohorts of TFs often act in unison to 
precisely modulate the transcription of specific target genes. Homeobox (Hox) genes are essential 
developmental TFs that pattern the body plan along the anterior-posterior, and the appendages 
along the proximal-distal axes. During embryonic development, they are expressed in a nested 
fashion and perform partially redundant functions. Furthermore, in vitro analysis of HOX-DNA 
binding identified overlapping sequence preferences that can be altered in the presence of 
specific cofactors. However, functional and biochemical investigation of genome-wide HOX 
binding patterns and delineation of individual Hox functions has been futile due to high protein 
homology, lack of specific antibodies, and nested expression domains. Due to lack of evidence, 
low in vitro HOX-DNA specificity and highly specific Hox functions have often been at odds, 
creating a so-called Hox paradox. 
This study aimed to overcome these issues and investigate Hox paradox at the DNA binding 
level. For this, nine chicken limb-specific posterior HOXA and HOXD genes were FLAG-
tagged, and overexpressed in limb-derived mesenchymal stem cells. In this system, native HOX 
cellular environment is preserved, and a unique epitope is created facilitating investigation of 
HOX-DNA binding and characterization of transcriptional programs induced by individual 
HOX. 
In this system, individual HOX overexpression induces highly redundant regulatory programs. 
The extent of transcriptional redundancy within paralogy groups differs, with PG9 and PG13 
inducing quite distinct, and PG10 and PG11 remarkably redundant regulatory programs. 
Likewise, HOX-DNA binding exhibits redundancy between and within paralogy groups. In line 
with the transcriptional redundancy, binding within PG10 and PG11 is more redundant than 
within PG9 and PG13. Furthermore, HOX bind DNA both directly and indirectly. Direct 
binding motifs discovered in this study are considerably different from the known monomer-like 
HOX motifs described in vitro. The change is mainly attributed to TALE and other yet 
undetermined cofactors. In contrast, indirect binding is responsible for a remarkable abundance 
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of HOX-DNA binding sites. Detailed inspection of HOX binding profiles identified 
subgrouping into two groups, Group 1 and Group 2. This subgrouping is linked to the 
abundance of indirect binding and partially to the CTCF mediated indirect binding. Moreover, 
binding sites co-occupied by both HOX and CTCF almost always exhibit additional Cohesin 
binding, indicating that these triple bound sites could have a role in the establishment and/or 
maintenance of local genome micro-architecture and chromatin remodeling. Finally, CTCF is 
confirmed as a novel HOX cofactor using two independent assays, implying that at least part of 
the contacts between HOX and CTCF are mediated through protein-protein interactions, 
whether directly or in a complex. 
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Zusammenfassung 
 
Ein mehrzelliges Lebewesen entwickelt sich zum erwachsenen Organismus aus einer einzelligen 
Zygote. Eine hoch koordinierte Genregulation während der embryonalen Entwicklung 
ermöglicht die Differenzierung der Zygote in verschiedene Gewebe- und Zelltypen. Der Ablauf 
der Entwicklungsprozesse wird weitgehend durch Transkriptionsfaktoren (TFs) vermittelt. TFs 
sind DNA-bindende Proteine, die die Expression anderer Gene regulieren. Deren Bindung kann 
als Monomer, Hetero-, Homodimer oder als TF-DNA Bindungskomplexe erfolgen. Oft bilden 
TFs Komplexe miteinander und modulieren als solche die präzise Transkription spezifischer 
Zielgene. 
Homöobox-Gene (Hox) sind wichtige TFs, die während der Entwicklung den Körperplan 
entlang der anteroposterioren Achse und die Anhänge entlang der proximodistalen Achse 
bestimmen. Während der embryonalen Entwicklung werden die Hox-Gene in verschachtelter 
Weise exprimiert und sind zum Teil redundant in ihren Funktionen. In vitro HOX-DNA-
Bindungsanalysen ergaben überlappende Sequenzpräferenzen, die sich in Gegenwart von 
spezifischen Kofaktoren verändern. 
Die funktionelle und biochemische Untersuchung von genomweiten HOX-Bindungsmustern 
und die Bestimmung der Funktionen einzelner Hox-Gene werden durch die hohe 
Proteinhomologie, unzureichend spezifische Antikörper und verschachtelte Expressionsdomänen 
erschwert und blieben bisher erfolglos. Der Mangel an Beweisen, die niedrigen HOX-DNA-
Bindungsspezifität in vitro und die hochspezifischen Hox-Funktionen, die oft im Widerspruch 
stehen, führten zur Entstehung des so genannten Hox-Paradoxons. 
Das Ziel dieser Arbeit bestand darin, diese Probleme zu überwinden und das Hox-Paradoxon in 
Bezug auf die DNA-Bindung zu untersuchen. Zu diesem Zweck habe ich neun Gliedmaßen-
spezifische posteriore HOXA- und HOXD-Gene mit dem FLAG-Epitop markiert und diese in 
Gliedmaßen-mesenchymalen Stammzellkulturen überexprimiert. In diesem System wird die 
native HOX-Zellumgebung bewahrt. Dadurch wird die Untersuchung der HOX-DNA-Bindung 
und die Charakterisierung von Transkriptionsprogrammen, die durch einzelne HOX-TFs 
induziert werden, ermöglicht. 
Die Überexpression der einzelnen HOX-TFs induziert hochgradig redundante 
Regulierungsprogramme. Das Ausmaß der Transkriptionsredundanz innerhalb der Paralogie-
Gruppen (PG) unterscheidet sich: PG9 und PG13 induzieren deutlich unterschiedliche 
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Regulationsprogramme, während PG10 und PG11 stark redundant wirken. Die HOX-DNA-
Bindung weist zugleich Redundanz zwischen und innerhalb von Paralogie-Gruppen auf. Im 
Einklang mit der Transkriptionsredundanz ist die HOX-DNA-Bindung zwischen PG10 und 
PG11 redundanter als zwischen PG9 und PG13. Genomweit können HOX sowohl direkt als 
auch indirekt an die DNA binden. Die in dieser Studie entdeckten direkten Bindungsmotive 
unterscheiden sich erheblich von den in vitro Monomer-ähnlichen HOX-Motiven. Diese 
Unterschiede sind hauptsächlich auf TALE und andere noch unbestimmte Kofaktoren 
zurückzuführen. Im Gegensatz dazu kommt es an einer bemerkenswert hohen Anzahl von 
HOX-DNA-Bindungsstellen zu einer indirekten Bindung. Im Besonderen das genomweite 
HOX-Bindungsprofil lässt sich unerwartet in zwei Gruppen unterteilen, Gruppe 1 und Gruppe 2. 
Diese Unterteilung steht mit der Menge der indirekten Bindungen und teilweise mit der CTCF-
vermittelten indirekten Bindung in Zusammenhang. 
Die Bindungsstellen, die sowohl von HOX als auch von CTCF erkannt werden, weisen sehr oft 
eine zusätzliche Cohesinbindung auf. Dies deutet darauf hin, dass diese dreifach gebundenen 
Stellen eine Rolle bei der Etablierung und/oder bei der Aufrechterhaltung der lokalen Genom-
Mikroarchitektur und der Chromatin-Remodellierung spielen könnten. 
Letztendlich wurde mittels zwei unabhängiger Experimente nachgewiesen, dass CTCF als 
neuartiger HOX-Kofaktor fungiert. Darüber hinaus besteht die Möglichkeit, dass zumindest ein 
Teil der Interaktionen zwischen HOX und CTCF indirekt in einem Komplex oder durch direkte 
Protein-Protein-Wechselwirkungen zustande kommt.  
 
 
 
1  Introduct ion 
 
Embryonic development is a complex and highly coordinated process where the embryo 
develops from the one-cell stage zygote to fully functional embryo with hundreds of specialized 
cell types. Therefore, all cells in the organism carry the same genetic information but still greatly 
differ from one another. This is accomplished through precise and timely gene expression which 
is often modulated by sequences and factors outside of the gene body itself. Finally, such 
accurate and titrated gene expression is monitored at multiple checkpoints at different levels; 
from transcription until translation.  
1.1 Transcriptional Regulation 
Transcriptional regulation is the first and most robust step in the control of gene expression. 
Simply put, transcriptional regulation is the regulation of timing and positioning of RNA 
polymerase II (RNA Pol II). This is achieved through regulation both in cis and trans, before and 
during the RNA transcription. While, generally, all genes are regulated on the transcriptional 
level, a specific group of genes, developmental genes, have to be expressed very specifically in 
space and time and therefore require extremely accurate transcriptional regulation. Below, I will 
focus on the most important aspects of transcriptional regulation of developmental gene 
expression. 
1.1.1 Promoters 
Promoters are gene proximal elements located immediately upstream of a transcription start site 
(TSS) that drive transcription. Promoters contain sequences that are essential for the recruitment 
of RNA Pol II and the formation of the preinitiation complex (PIC). The PIC is formed when 
general transcription factors (GTF) bind sequences upstream of the promoter triggering the 
nucleosome displacement and making the DNA accessible. Concomitantly, the chromatin state 
changes e.g. the histones get acetylated or methylated, thereby facilitating transcription (Figure 
1.1) (Lee & Young 2000; Spitz & Furlong 2012; Kadonaga 2012). Formation of the PIC and the 
start of the transcription is guided by the elements present in the core promoter of every gene. 
Promoters of developmental genes contain a TATA box, the initiator, and the downstream 
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promoter element (DPE) that guide correct positioning of the RNA Pol II, PIC assembly, and 
instruct precise and accurate start site of the transcription (Roeder, 1996).  
1.1.2 Enhancer Elements 
Enhancers are cis-regulatory elements (CRE) that can activate a promoter and drive the 
transcription of a target gene. In contrast to the promoters, enhancers can act from both sides of 
the target TSS, in any orientation, and over extremely long linear distances (Banerji, Rusconi and 
Schaffner, 1981; Moreau et al., 1981; Lee and Young, 2000; Lettice et al., 2003; Sagai et al., 2004). 
The discovery and localization of enhancers in animal genomes indicated that it is common for 
enhancers to be located far away from the cognate promoter, in the intergenic space or introns of 
other genes raising the question: How do the enhancers activate their target promoter and how 
do they achieve tissue specificity? 
Answering this question is all but a trivial matter as tissue specific gene expression can be driven 
by one or more different enhancers. Furthermore, these enhancers can act in different tissues 
(tissue specific enhancers) or several enhancers can act together in the same tissue. Exemplarily, 
the Shh gene encodes a morphogen that is active in several tissues, including forebrain and limb 
 
 
Figure 1.1 Schematic representation of the transcriptional initiation at an active gene. 
Red rectangle and ovals represent inactive gene and cis-regulatory elements (CREs), respectively. Green rectangle 
and ovals represent active gene and cis-regulatory elements, respectively. In this case green CRE1 is a cis-regulatory 
element that is not active in the same tissue like CRE2, CRE3, and CRE4. In the scheme, active gene is contacted 
by the distal CREs that are bound by specific transcription factors (TFs). In order to come in the proximity to the 
promoter of the gene, the distal elements have to be physically moved closer, a process here referred to as looping. 
It is not fully clear how looping occurs at all positions in the genome but most often CTCF and Cohesin facilitate 
such conformational change, as depicted above. To allow for the transcription to occur at the promoter site general 
transcription factors (GTFs) have to be present as well as the histone readers, erasers and writers which will 
facilitate chromatin remodelers and facilitate start of the transcription via the RNA Pol II. 
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bud. In these two tissues, the expression of Shh is driven by tissue specific enhancers. In the limb, 
only by one enhancer, the ZRS,  and in the forebrain by several different enhancers (Lettice et al., 
2003; Jeong et al., 2006). Enhancers’ tissue specificity is usually mediated by the presence or 
absence of the transcription factor binding sites (TFBS) at the enhancer body. Comparative 
analyses of enhancers between species indicated that some enhancers contain conserved 
transcription factor binding sites (TFBS) (Nobrega and Pennacchio, 2004; Kvon et al., 2016). 
These TFBSs are instrumental for enhancers function as they allow them to operate in a modular 
fashion (Figure 1.1). Specifically, multiple TFBSs at the enhancer may provide malleability when 
activating the target gene in different tissue or time (Kulkarni and Arnosti, 2003; Arnosti and 
Kulkarni, 2005). Furthermore, a recent study has demonstrated that the TFBSs at enhancers are 
often sub-optimal. When these sub-optimal TFBSs were exchanged with high-affinity binding 
sites, target gene was both over- and misexpressed (Farley et al., 2015). Therefore, TFBSs at 
enhancers are essential for the appropriate and precise gene expression. 
1.1.3 Transcription Factors (TFs)  
While promoters and enhancers are DNA elements that control gene expression in cis, 
transcription factors are DNA binding proteins that provide an additional layer of gene regulation 
in trans. Transcription factors can be general (GTF), specific1, and structural. GTFs bind 
promoters whereas specific TFs bind enhancers and together they help bridge promoter and 
enhancer elements, form the PIC, and facilitate transcription (Figure 1.1). Additionally, structural 
TFs (e.g. CTCF) can arrange the chromatin geometry and in such manner impact the RNA pol II 
recruitment. 
However, only specific TF binding at enhancer elements can activate enhancers and through this 
activation to modulate their target gene’s activity (Deng et al., 2012). This process is dependent on 
several factors, namely, the DNA sequence, protein-protein interactions, direct and indirect 
cooperativity, and TF concentration in the nucleus. So far there is no unifying model to describe 
the mechanism of enhancer activation as findings from different loci point towards different 
mechanisms. Currently, three different models are used to describe TF-mediated enhancers 
activation (Spitz and Furlong, 2012).  
Research done on the interferon β enhancer suggests the logic of so-called enhanceosome 
model (Thanos and Maniatis, 1995; Merika and Thanos, 2001). Here, the enhancer contains 
                                                 
1 From here on specific transcription factors are just referred to as transcription factors (TFs), unless specified 
otherwise. 
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transcription factor binding sites (TFBSs) that are precisely spaced following a strict grammar. 
According to this model, as TFs act cooperatively by binding to each other and using DNA as a 
scaffold if the binding of one TF is abrogated the enhancer is unable to produce a transcriptional 
output. Such enhancers can produce on/off difference in gene expression from one cell to 
another allowing for sharp gradients to form (Thanos and Maniatis, 1995; Merika and Thanos, 
2001).  
In contrast, the billboard model is characterized by more flexible grammar where not all motifs 
at the enhancer need to be bound for a transcriptional output to be produced. This more relaxed 
grammar allows for the same enhancer to be activated in different cellular environments and 
tissues while producing a similar output (Kulkarni and Arnosti, 2003; Arnosti and Kulkarni, 
2005).  
Finally, the investigation of the cardiac development uncovered a set of five TFs that co-bind a 
large number of enhancers and together control the expression of their target genes. Surprisingly, 
the sites occupied by these five TFs do not possess almost any grammar; underlying motifs are 
flexible and TF binding is highly dependent on protein-protein interactions. This model is known 
as “collective transcription factor enhancer model” (Junion et al., 2012). 
Three models described above mainly tackle direct cooperativity and motif grammar. However, 
in addition to the TFs themselves, there are other proteins (cofactors) that affect TF binding 
affility and dynamics. Cofactors can be specific (e.g. TALE-HOX) and general; either general 
coactivators (e.g. p300) or general corepressors (e.g. HDAC). General cofactors are cofactors that 
do not act on all TFs and often affect TF resting time, DNA affinity, or DNA accessibility 
(Merika et al., 1998; Mann, Lelli and Joshi, 2009). Conversely, specific cofactors are targeting only 
a specific suggroup of TFs and can be tethering or sequence specific. One of the best known 
examples of specific tethering cofactors comes from the β-globin locus where distal locus control 
region (LCR) contacts β-globin promoter activating transcription. Importnantly, both, β-globin 
promoter and LCR are directly bound by the GATA1 transcription factor on top of which a an 
associated molecule, Ldb1, binds causing Ldb1 self-dimerization, looping LCR to β-globin 
promoter, and activates transcription (Deng et al., 2012). On the other hand, sequence specific 
cofactors heterodimerize with TFs and together co-bind to the DNA. Best known example of 
sequence specific cofactors is the HOX-TALE association. More specifically, Scr is a Drosophila 
Hox transcription factor which requires an association with Exd in order to bind a subset of its 
binding sites. Only in the case of the homodimerization, the Scr-Exd complex recognizes the 
I n t r o d u c t i o n    
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low-affinity conglomerate sites that Scr alone would not be able to recognize, therby facilitating 
the regulation of essential target genes (Crocker et al., 2015). Therefore, in order to produce 
precise and timely gene regulation the presence and coordination of GTFs, structural TFs, and 
both, tethering and sequence specific cofactors is required and necessary.  
1.1.4 Genome Architecture  
In addition to specific TFs and GTFs, structural TFs impact gene expression by altering the 
chromatin geometry. Structural TFs are a class of DNA-binding proteins that can assure the 
accuracy of gene expression by affecting the genome folding and some affect partitioning the 
genome into self-associating isolated units, topologically associated domains – TADs, 
characterized by more frequent DNA-DNA contacts within than outside of the domain (Figure 
1.1 and Figure 1.2). Recent studies uncovered that target genes and their enhancers mainly 
occupy chromatin belonging to the same TAD, indicating that genome architecture has a 
functional component to it. These units are usually several hundred kilobases up to a megabase in 
size and are flanked by a DNA stretch with insulating power separating two adjacent TADs 
(Figure 1.2). These DNA stretches are termed boundaries. Boundaries encompass DNA of tens 
of kilobases in size and are often associated with structural TFs like CCTC-binding factor 
(CTCF), Cohesin, and/or strong transcription (Dixon et al., 2012; Nora et al., 2012, 2016; Phillips-
Cremins and Corces, 2013; Zuin et al., 2013; Schwarzer et al., 2016). In addition to preferential  
boundary localization, CTCF together with Cohesin can mediate “looping” between two pieces 
of DNA within the TAD (e.g. enhancer-promoter contacts) (Zuin et al., 2013; Rao et al., 2014). 
Furthermore, it has been shown that the CTCF binding motif orientation plays a role in the 
formation of DNA loops. Specifically, when mediating loop formation two CTCF binding sites 
are almost exclusively in convergent orientation (de Wit et al., 2015; Guo et al., 2015). 
Additional to structural TFs, a recent study demonstrated that specific TFs can affect local TAD 
architecture as well. Beccari et al. (2016) demonstrated HOX13 proteins are essential for the 
switch from early to late limb regulation at the HoxD locus. More specifically, HoxD cluster is 
located directly at the boundary of two TADs and on the either side of the HoxD cluster are 
HOX enhancers that belong to different TADs, early enhancers to the tTAD and late enhancers 
to cTAD. During early limb patterning only early enhancers (tTAD) are active whereas during 
late patterning only late enhancers are active (cTAD). In Hox13 loss-of-function mouse the 
switch from early regulation (cTAD) to late regulation (tTAD) fails and mutant animals do not 
properly form the autopod. However, although these experiments clearly demonstrate that 
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HOX13 proteins govern the switch between early and late limb regulation, the exact mechanism 
of this TAD switch is still unclear.  
Taken together, recent discoveries clearly demonstrated that TFs utilize chromatin structure in 
order to modulate gene expression. In such manner, structural TFs (CTCF) mold the global 
genome architecture to restrict transcription to functional units, and specific TFs further 
manipulate local micro-architecture to instigate precise transcriptional output. 
1.2 Hox Genes 
Homeobox (Hox) genes are a gene family coding for transcription factors (TFs). Hox genes are 
highly conserved in all bilaterians where they direct patterning of the body plan along the 
anterior-posterior (A-P) and patterning of appendages along the proximal-distal (P-D) axis 
(Lewis, 1978; Akam, 1989). They were first identified during a large mutation screen in Drosophila, 
as they caused very peculiar phenotypes. Specifically, loss-of-function and gain-of-function 
 
 
Figure 1.2 Schematic representation of genomic architecture at an active and an inactive gene 
and their accompanying histone modifications. 
Red matrix on top represents a Hi-C map over the region of the genome. Red triangles are regions that 
predominantly interact more frequent with each other, so called, topologically associating domains (TADs). Under 
TADs there are either active or inactive genes where their respective cis-regulatory elements (CRE) either do or 
don’t contact the genes. Histone modifications mark genes and cis-regulatory elements. They bear marks as 
follows: 1) Active gene-H3K4me3, H3K27Ac, HK36me3 (over the gene body) and RNA PolII, 2) Inactive gene-
H3K27me3, 3) Active CRE-H3K27Ac, H3K4me2, RNA PolII, or none of the mentioned if the CRE is not active 
in the present tissue (green CRE closest to the active gene), and 4) Inactive CRE-H3K27me3 and if enhancer is 
poised additionally, H3K4me1. Adapted from (Ong and Corces, 2014). 
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mutations in Antp and Ubx genes cause the transformation of one body segment into the likeness 
of another, antennae-to-leg and haltere-to-wing, respectively (Lewis, 1978), a phenomenon 
termed Homeotic transformation.  
All Hox genes are characterized by three properties. First, by the clustered nature of the Hox 
genomic organization (Pascual-Anaya et al., 2013). Second, Hox genes are expressed in a 
nested and overlapping pattern according to their relative genomic position on the 
chromosome, both in time (e.g. Hox1 is expressed first) and space (e.g. Hox1 is expressed most 
anterior). This pattern of expression is referred to as spatiotemporal collinearity. Third, they 
contain a conserved DNA binding domain, the Homeodomain (HD). This is a 60 amino acid 
(aa) sequence (with the exception of TALE (Three Amino Acid Loop Extension) proteins which 
have 63aa Homeodomain) located at the C-terminal part of all Homeoproteins (Gehring et al., 
1994). Below, I will focus on vertebrate Hox genes during limb development and on the 
properties of HOX-DNA binding. 
1.2.1 Vertebrate Hox Genes 
In tetrapod vertebrates there are 39 Hox genes organized in four clusters on four different 
chromosomes. In higher animals, Hox genes increased in number with the series of tandem and 
whole genome duplications from a single — proto-Hox — cluster. After cluster duplications, the 
evolutionary pressure on the newly duplicated genes temporarily reduced creating “window of 
evolvability” (Wagner, Amemiya and Ruddle, 2003). Due to increased susceptibility to genomic 
changes Hox genes were more likely to adopt a new function or to disappear. This process is 
visible in higher organisms where in spite of the fact that four Hox clusters are present (HoxA, 
HoxB, HoxC, and HoxD) only three paralogy groups (PG) contain all four paralogues, those are 
PG4, PG9, and PG13 (Figure 1.3) (Wagner, Amemiya and Ruddle, 2003). Due to these 
processes, today, there is more pronounced functional divergence within the paralogy group that 
contains all four paralogues than within paralogy groups missing one or more paralogues. This 
will be discussed in more detail in Chapter 4.4 and Chapter 5.1.2. 
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1.2.2 Hox Function in Developing Limb Bud 
Vertebrate Hox genes are homologous and as such, functionally partially redundant. Just like in 
flys, they are essential for patterning of the body plan along the A-P axis, but also for 
development of other novel structures like: metanephric kidneys, lungs, intestines, genitalia, and 
limb buds (Akam 1989; Gong et al. 2007; Di-Poi et al. 2007; Zakany & Duboule 2007; Kondo et 
al. 1997; Featherstone et al. 1988). In the developing limb bud, almost exclusively, only nine 
posterior Hoxa and Hoxd genes are expressed (Hoxa9-13 and Hoxd9-13) in overlapping patterns 
which allow them to build the limb structures in a combinatorial fashion (Figure 1.4A, B, and 
C). In such way, Hox9 and Hox10 paralogues mainly pattern zeugopod, Hox11 stylopod, and 
Hoxd12 and Hox13 paralogues pattern autopod (Small & Potter 1993; Davis & Capecchi 1994; 
Fromental-Ramain et al. 1996; Kmita et al. 2002; Kmita et al. 2005; Duboule 2007). 
So far, geneticists used mainly loss-of-function and knock-out experiments to decipher individual 
Hox gene functions. Knock-out mice of, Hoxa11 or Hoxd11 gene exhibit only mildly misshapen 
 
 
Figure 1.3 Phylogenetic tree showing emergence from the proto-Hox cluster to four Hox 
clusters in vertebrates. 
Hox have emerged from a proto-Hox cluster in bilateral ancestor that was subjected to changes throughout 
evolution. In roundworms some genes get lost. In arthropods, molluscs, echinoderms and cephalochordates a 
series of different tandem duplications multiply the genes. Finally, in tetrapods with the two rounds of whole 
genome duplications four Hox clusters emerge with total of 39 genes. Adapted from (Genetic Science Learning 
Center, 2016). 
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ulna and radius. However, a double Hoxa11/d11 knock-out mutant mouse presented a striking 
reduction in the size of ulna and radius that was not present in the knock-out of either Hoxa11 or 
Hoxg11 alone (Davis et al., 1995). These experiments demonstrated both the importance of the 
Hox11 paralogues for the development of zeugopod and their individual functional 
redundancies. Similarly, Hoxa10/d10 loss-of-function mice exhibited a noticeable reduction in 
femur indicating the importance of the Hox10 paralogues for the stylopod patterning (Wellik & 
Capecchi 2003; Fromental-Ramain et al. 1996) whereas the Hoxa13/d13 loss-of-function mice 
exhibit a completely abrogated autopod development revealing Hox13 genes as master regulators 
of autopod development (Dolle et al. 1993; Fromental-Ramain et al. 1996). Additionally, these 
findings were substantiated with an elegant series of genetic experiments where and entire HoxA 
and/or HoxD clusters were deleted (Figure 1.5). Surprisingly, the deletion of a single cluster, 
either HoxA or HoxD, lead only to very mild phenotypic consequences for the developing limb. 
However, upon the deletion of both clusters (HoxA and HoxD) limb bud development halts and 
only the most proximal structures of the limb develop (scapula) revealing the extent of 
redundancy between these genes (Kmita et al., 2002; Marie Kmita et al., 2005). 
Importantly, Hox functional redundancy extends beyond their own paralogy group as some 
neighboring genes are found to be partially redundant as well (Zakany & Duboule 2007; 
Woltering & Duboule 2010). Exemplarily, the experiments where the Homeodomain of one Hox 
gene was swapped for the Homeodomain of another Hox gene have demonstrated that some 
Homeodomains are interchangeable to no phenotypic expense whereas others are not (Zhao and 
Potter, 2002). This was further elaborated and extended with a series of in vivo experiments. In 
those studies, a deletion of Hoxd13 gene caused Hoxd12 gene to take the terminal position in the 
HoxD cluster and Hoxd12 gene to adopt a Hoxd13 pattern of expression. Surprisingly, however, 
the phenotypic consequence of this perturbation was barely noticeable (Kmita et al., 2002). 
Conversely, when Hoxd13 was mutated and the HOXD13 protein rendered inactive, but not 
removed from the genome, Hoxd12 expression was restricted to its own endogenous domain and 
the mice exhibited polydactyly which was not present in Hoxd13 deletion. Next, the same logic 
was followed for the experiments where Hoxd13 and Hoxd12 were deleted causing the Hoxd11 
gene to relocate to the Hoxd13 position. Expectedly, this caused Hoxd11 to adopt Hoxd13 gene 
expression domain. Surprisingly, however, this perturbation caused polydactyly which was even 
more severe than polydactyly present in the Hoxd13 loss-of-function mice (Kmita et al., 2002). 
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Together, these genetic experiments indicate two important characteristics of Hox gene function 
in the limb bud, nested expression pattern and redundancy. Nested, but distinct expression 
domains are essential and necessary for fine tuning of patterning and differentiation. However, 
even if expressed in the same expression domains, not all Hox genes are equivalently redundant, 
and the extent of redundancy, although most prominently present in the individual paralogy 
groups, extends to the neighboring genes as well (e.g. Hoxa13-Hoxd13 but also Hoxd12-Hoxd13). 
1.2.3 HOX-DNA Binding 
HOX proteins’ main function is DNA binding that is carried out by the most conserved part of 
the protein, the Homeodomain. The Homeodomain forms three alpha helices connected with 
turns where first two helices mainly stabilize the binding and a third, the most C-terminally 
positioned, is the recognition helix responsible for most of the sequence recognition on the 
DNA. HOX-DNA binding is mainly mediated through amino acids at the positions 47, 50, 51 
and 54 of the Homeodomain which code for the Ile, Gln, Asn, and Met (Met can be replaced by 
Val in HOX13, in Aves), respectively (Gehring et al., 1994). Furthermore, amino acids mediating 
 
 
Figure 1.4 Schematic representation of Hoxa and Hoxd expression in early and late limb bud, 
and their contribution to the limb morphology. 
A) Hoxa and Hoxd are expressed in limb-covering, nested domains in the early limb bud. B) In  late limb bud this 
nested pattern continues with the exception that Hoxd genes are not expressed in the future wrist area. C) Fully 
developed limb arises with the anatomically specific contributions of Hox genes. PG9 and PG10 help shape the 
zeugopod, PG10 and PG11 the stylopod and PG13 and Hoxd12, almost exclusively, shape the autopod (right 
panel). According to (Zakany & Duboule 2007). 
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this HOX-DNA contact are extremely conserved in all bilateria emphasizing the preservation of 
the DNA binding mechanism in this protein family. However, despite high conservation of direct 
binding specificity driven by Homeodomain (due to the high protein homology), HOX proteins 
exhibit diverse function in vivo (Mann, Lelli and Joshi, 2009). This discrepancy between HOX 
biochemical redundancy and functional specificity has been termed HOX Paradox.  
Several large-scale studies examined Homeodomain specificity in vitro, both in fruit fly and mouse 
(Noyes et al. 2008; Berger et al. 2008; Slattery et al. 2011; Jolma et al. 2013; Jolma et al. 2015). In 
mouse, posterior paralogues bind four classes of motifs: HOXA9/A10/D10 TFs bind the 
[C/T][A/C]ATAAA; HOXA11/D11 bind CTCGTAAA; and HOXA13/D13 bind, both 
CTCGTAAA and CCAATAAA motifs (Berger et al. 2008; Zhang et al. 2011; Turner et al. 2014). 
These findings indicate significant overlap between different HOX binding specificities while it is 
known from various genetic experiments that they perform distinct roles in the developing 
embryo. Therefore, full in vivo binding specificity must rely on additional cofactors, both co-
binding and perhaps tethering the HOX proteins, in order to confer the appropriate HOX 
function(s). Very little is known about HOX binding in vivo and about their cofactors. Up-to-date 
most of what we know about HOX-cofactor binding comes from the best known HOX 
cofactors, Three Amino Acid Loop Extension (TALE) proteins. They are Homeodomain family 
of TFs conserved from plants to animals and in Vertebrates come in two subfamilies PBC (Pbx1-
4) and MEIS/PREP (Meis1-3 and Prep1-2) (Mukherjee and Bürglin, 2007). HOX and TALE 
proteins co-bind and alter sequence specificity before binding to DNA (LaRonde-LeBlanc and 
Wolberger, 2003). Specifically, HOX contact PBC proteins through N-terminally positioned 
Hexapeptide (HX) motif that consists of YPWM amino acids and with HX contacts PBC’s 
Homeodomain. TALE TFs have three additional amino acids in their Homeodomain, from 
where they get their name, which PBC proteins use to make a hydrophobic cavity where Hox 
Hexapeptide (HX) motif binds to PBC’s Tryptophan (W) (Mann, Lelli and Joshi, 2009). 
Additionally to the HX motif, on the C-terminal part of the HOX Homeodomain, there are short 
motifs that drive specific HOX-PBC contacts, collectively known as SPIM sequences (specific 
PBC interaction motifs). They drive specific interactions only in a subset of HOX proteins as 
they are not particularly well conserved and are not present in all HOX proteins. 
Taken together, aforementioned in vitro analyses focused mainly on direct Homeodomain-DNA 
binding specificity. However, because of the large-scale scope of these analyses they did not focus 
on specificities of cofactor driven HOX binding and therefore could not account for the actual in 
vivo specificity of these complexes. Indeed, the study using SELEX-seq identified significant 
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changes in sequence specificity occurring once HOX co-bound with TALE proteins (Slattery et 
al., 2011). This phenomenon where the sequence specificity is changed upon the binding with 
another protein is known as latent specificity and at least partially explains the Hox Paradox. 
Furthermore, an in vivo study examining multiple HOX binding sites in Drosophila found that 
high-affinity binding sites do not entail biological importance of these sites, but rather the 
opposite. In other words, the more specific the binding site (e.g. only one HOX paralogue can 
bind, or only HOX paralogue with a cofactor), the lower affinity of the site (Crocker et al., 2015). 
It is not entirely clear why the specificity inversely correlates with the affinity. However, it is clear 
that common (i.e. where any HOX-TF can bind) consensus sites are high-affinity sites that often 
are not of utmost biological relevance, in contrast to the hybrid HOX-cofactor sites. 
In this project, the latent specificity was encountered as well, indicating that low-affinity, 
biologically important sites are common and a general feature of HOX binding. These findings 
will be discussed in detail in Chapter 4.5.4, Chapter 5.2.1, and Chapter 5.2.3. 
 
 
Figure 1.5 Schematic representation of Hoxa and Hoxd deletion experiments and their 
contribution to the limb related phenotype. 
A wild-type and five deletion experiments with entire HoxD, entire HoxA, entire HoxD and HoxA, PG13, and 
PG11 deletions, respectively, with their related limb phenotypes depicted under the genotype.  According to 
(Zakany & Duboule 2007). 
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Additional to binding specificity conferred by specific cofactors, binding can be influenced by 
general cofactors as well. Specifically, HOX were shown to associate with CBP/P300 proteins to 
more efficiently regulate its expression. CBP/p300 proteins contain a histone acetyltransferase 
(HAT) domain that can normally acetylate histones and help activate the target gene. 
Interestingly, however, with HOX, CBP acts as a corepressor rather than coactivator. CBP binds 
with HOX in a complex before it reaches the DNA which prevents HOX-DNA binding. 
Additionally, when HOX-CBP form a complex CBP’s HAT activity is blocked leading to 
downregulation and not upregulation of target genes (Shen et al., 2001). Finally, one of the very 
few evidence of tethered HOX binding was demonstrated for the HOXD13 mutated protein, 
where HOXD13 DNA binding activity has been abolished. Interestingly, such HOXD13 mutant 
was able to upregulate some targets much like its wild-type counterpart. However, this construct 
was unable to negatively regulate some of its own targets (Williams, Williams, Kuick, et al., 2005). 
Together, these two examples demonstrate that subsets of binding sites in the genome 
undoubtedly rely on the mechanisms that circumvent both the direct and TALE modified direct 
binding. However it is still unclear how abundant are indirect and tethered binding and how 
important they are for the HOX function.  
In conclusion, HOX binding sites are extremely heterogeneous. Source of such heterogeneity are 
various binding modules of HOX-TFs as they utilize both specific and general cofactors. The 
combination of nested expression patterns, specific cell type cofactors, and specific HOX 
cofactors allow transformation of initially unspecific Homeodomain recognition motif into a 
precise output. The knowledge and investigation of this complex regulatory input will permit a 
better understanding of Hox paradox and help elucidate how HOX-TFs exert their function.   
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2  Aim of the Thesis  
 
Homeobox (Hox) genes are essential developmental transcription factors that pattern the animal 
body. They are expressed in an overlapping pattern along the trunk, in the developing 
appendages, and organs. In the developing limb bud, mainly posterior nine Hoxa and Hoxd genes 
are expressed. Posterior HOXA and HOXD proteins are highly homologous and function in a 
partially redundant manner. In vitro examination of the HOX-DNA binding preferences 
uncovered remarkably similar sequence specificity. The inconsistency between nearly identical in 
vitro binding and specific Hox TF function is at the core of problem known as a Hox paradox. 
To address this paradox, it is necessary to study HOX-DNA binding in vivo and in a Hox native 
environment. However, overlapping Hox genes expression patterns, high protein homology, and 
lack of highly specific antibodies prevented these analyses for years. The aim of this study is to 
address the inconsistencies known as a Hox paradox by exploring HOX-DNA binding in vivo. 
To do so, this study utilized a primary cell-culture system to provide a native Hox cellular 
environment. Additionally, a unique epitope was fused with the Hox genes allowing 
discrimination between individual HOX proteins. Using this system together with a combination 
of genomics, genetics, and biochemical approaches the genome-wide binding profiles and 
individually induced transcriptional programs of nine posterior HOXA and HOXD TFs were 
investigated. Finally, the direct and indirect HOX-DNA binding were uncovered as HOX 
binding modes, where the focus was on the indirect, noncanonical HOX binding and on 
cofactor(s) that aid this process.  
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3  Materia l  and Methods  
3.1 Materials  
3.1.1 Chemicals 
Unless stated otherwise, chemicals were obtained from Merck (Darmstadt), Roth (Karlsruhe) or 
Sigma-Aldrich (Hamburg, Seelze, Schnelldorf, and Steinheim) in analytical grade quality.  
3.1.2 Buffers 
Common buffers and solutions were prepared according to Sambrook & Russell (2001). 
Buffers for Chromatin Immunoprecipitation: 
Lysis Buffer 1: 
50mM HEPES-KOH, pH7.5; 140mM NaCl; 1mM EDTA; 10% 
Glycerol; 0,5% NP-40; 0,25% Triton X-100; Protease Inhibitors 
(Roche complete, add fresh) 
Lysis Buffer 2: 
10mM Tris-HCl, pH 8.0; 200mM NaCl; 1mM EDTA; 0.5mM 
EGTA; Protease Inhibitors (Roche complete, add fresh) 
Lysis Buffer 3: 
10mM Tris-HCl, pH 8.0; 100mM NaCl; 1mM EDTA; 0.5mM 
EGTA; 0,1% Na-Deoxycholate; 0,5% N-Laurylsarcosine; Protease 
Inhibitors (Roche complete, add fresh) 
RIPA (Wash Buffer) : 
50mM HEPES-KOH, pKa 7.55; 500mM LiCl; 1mM EDTA; 1,0% 
NP-40; 0,7% Na-Deoxycholate; Protease Inhibitors (Roche 
complete, add fresh) 
TE-NaCl: 
10mM Tris-HCl, pH 8.0; 1mM EDTA; 50mM NaCl, Protease 
Inhibitors (Roche complete, add fresh) 
ChIP-Elution Buffer: 50 mM Tris-HCl, pH8.0; 10mM EDTA, 1.0% SDS 
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Buffers for Co-Immunoprecipitation: 
Low-salt Buffer: 
10 mM HEPES-KOH, pH 7.9; 1.5 mM MgCl2; 10 mM KCl; 0.5 mM 
DTT; 0.2 mM PMSF; Protease Inhibitors (Roche complete, add 
fresh) 
High-salt Buffer: 
20 mM HEPES-KOH, pH 7.9; 25% Glycerin; 420 mM NaCl; 1.5 
mM MgCl2; 0.5 mM DTT; Protease Inhibitors (Roche complete, add 
fresh) 
Blocking Buffer: 0.25% BSA in Wash Buffer 105 
BS3 Conjugation Buffer: 150mM NaCl; 20mM NaH2PO4 
BS3 Stock Solution: 
2 mg of BS3 (Thermo Fisher Scientific, #21585) in 35 µL BS3 
Conjugation Buffer 
BS3 Working Solution: 5% BS3 Stock Solution in BS3 Conjugation Buffer 
Quenching Buffer: Tris-HCl, pH 7.5 
IP Buffer: 
20mM HEPES-KOH, pH 7.9; 1.5mM MgCl2; 0.5mM DTT; 
105mM NaCl; 6.25% Glycerin; sterile filter; Protease Inhibitors 
(Roche complete, add fresh) 
Wash Buffer 105: 
20mM HEPES-KOH pH 7.9, 1.5mM MgCl2, 0.5mM DTT, 105mM 
NaCl, sterile filter; Protease Inhibitors (Roche complete, add fresh) 
Wash Buffer 150: 
20mM HEPES-KOH pH 7.9, 1.5mM MgCl2, 0.5mM DTT, 150mM 
NaCl, sterile filter; Protease Inhibitors (Roche complete, add fresh) 
Co-IP Elution Buffer: 50mM Tris; 1% SDS; 10mM EDTA 
 
Buffers for Proximitiy Ligation Assay: 
PLA Blocking Solution 
(TSA): 
10% horse serum; 0,5% PerkinElmer blocking reagent (#FP1020); 
0.01% Triton-X-100 in 1x DPBS 
PLA Antibody Diluent: 10% horse serum in 1x fresh DPBST 
PLA Buffer A: 0.01 M Tris, 0.15 M; NaCl; 0.05% Tween 20; sterile filter 
PLA Buffer B: 0.2 M Tris; 0.1 M NaCl; sterile filter 
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3.1.3 Media 
Table 3.1 Cell Culture Media 
Name of the media Supplier and catalog number 
DMEM; 4.5g/L Glucose Lonza #12-614F 
DMEM; 1g/L Glucose Lonza #12-707F 
DMEM Ham‘s F-12 (1:1) Biochrom #F4815 
3.1.4 Antibodies  
Table 3.2 Antibodies  
Antibody name Supplier and catalog number 
Mouse αFLAGM2 Sigma-Aldrich, #F1804-5MG 
Mouse αHA (HA11.1 epitope tag) BioLegend, #901501 
Rabbit αCTCF Active Motif, # 61311 
Rabbit αRAD21 Abcam, #ab992 
Rabbit αH3K4me3 Millipore, #07-473 
Rabbit αH3K27me3 Millipore, #07-449 
Goat αmouse IgG HRP Millipore, #12-349 
Normal Rabbit IgG Cell Signaling Technology, #2729 
 
Protein G magnetic beads were purchased from Invitrogen (Dynabeads, #100.04D). 
3.1.5 Enzymes 
Restriction enzymes were purchased from NEB (Frankfurt) or MBI-Fermentas (St. Leon-Roth). 
Taq- and Pfu-DNA-polymerases were produced in-house (A.C. Stiege). Phusion DNA-
Polymerase was purchased from NEB, T4-ligase, and Polymerase from MBI- Fermentas, and 
RNase A (# R4875) and Proteinase K (# P2308) from Sigma-Aldrich. 
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3.1.6 Primers 
Table 3.3 HOX and CTCF Amplification and Cloning Primers 
Name Sequence (5‘→3‘) 
chHoxA9_F CGCGTCTCCCATGTCGGCCCCCGGGACCCTC 
chHoxA9_R CGACTAGTTCATTCGTCCTTCGCTCGGTCTTTGTTGATTTTCTTC 
chHoxA10_F CCCGTCTCCCATGTCATGCTCCGAGAGCCCGGC 
chHoxA10_R CGAACTAGTTCAAGAGAAATTAAAGTTGGCTGTGAGCTCCC 
chHoxA11_F CCTCATGATGGATTTTGATGAGCGTGTTCCTT 
chHoxA11_R CTAACTAGTTTAAAGTAGTGGATTAGCTGAGTAATATTGTAA 
chHoxA13_F GCACATGTTCCTCTACGACAACAGCCTGGATGAG 
chHoxA13_R TAACTAGTTAACTGGTCGTCTTCAATTTGTTGATGAC 
chHoxD9_F TCATGATGTCGTCTAGTGGCACCATAAG 
chHoxD9_R CCACTAGTTAGTCTCCTTTATTGCCT 
chHoxD10_F CCACATGTCCTTTCCCAACAGCTC 
chHoxD10_R CCACTAGTTTAGGAGAAGGTCAGATTAG 
chHoxD11_F CCTCATGACCGAGTTTGACGATTGCAGTCACG 
chHoxD11_R CCACTAGTCAAAACAAGGGATTTCCAGTGAAGTATTGG 
chHoxD12_F CCCGTCTCACATGTGTGATCGCAGTCTCTACAGATCTGGCTAC 
chHoxD12_R GCACTAGTACATAGAGAGCGCCTGCTCGCG 
chHoxD13_F CGGAAGACGACATGGACGGACTGCGCGGCG 
chHoxD13_R CGACTAGTCAAGAAACGTTGTCTTTCAGTTTGGAGAC 
chCTCF_gibFL_F AGGATGACGATGACAAGTCCATGGAAGGTGAAGCAGTTGAAGCCA 
chCTCF_gibFL_R TGGCTTCAACTGCTTCACCTTCCATGGACTTGTCATCGTCATCCT 
chCTCF_gibHA_F CCGATTACGCCAGCAAGTCCATGGAAGGTGAAGCAGTTGAAGCCA  
chCTCF_gibHA_R TGGCTTCAACTGCTTCACCTTCCATGGACTTGCTGGCGTAATCGG 
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Table 3.4 Primers for Cloning of HOXA10 Deletion Constructs 
Name Sequence (5‘→3‘) 
F_chA10_∆1-60 ATGCTGTTCCCCGTCCTGGGCAA 
R_chA10_∆1-60 GGACTTGTCATCGTCATCCT  
F_chA10_∆60-120 TCCTACTGCCTCTATGACTC  
R_chA10_∆60-120 TCCGCAGCCCTGCAGCCCGT 
F_chA10_∆120-180 GCCGGGACGGCCCCCTTCGC 
R_chA10_∆120-180 GCTCTCCTCCTTAATGTTTT  
F_chA10_∆180-240 CCCGCGCCGTCGGAGGGCAG  
R_chA10_∆180-240 CGGCCCCGCGCCGTAGCCCT 
F_chA10_∆240-270 AAAAGTGGCCGAAAGAAACG  
R_chA10_∆240-270 GGAGAGCTCCTCGGCGGTGG  
F_chA10_∆170-200 CCGCCCGTGCCGGAGGCGGG 
R_chA10_∆170-200 GTAAGCCTGGGAGAGGCGGA 
F_chA10_∆270-347 TGAACTAGTTACGATGCGATGTA 
R_chA10_∆270-347 TGAACTAGTTACGATGCGATGTA 
 
Table 3.5 Sequencing Primers  
Name Sequence (5‘→3‘) 
chHoxA9_seq_F ACCTACCAGCAGGCATTACG 
chHoxA9_seq_R CGGTCCCTGGTGAGATACAT 
chHoxA10_seq_F1 AGGTACTTCGCAAAGCATGG 
chHoxA10_seq_R1 CTGGGAGAGGCGGAAGTAG 
chHoxA10_seq_F2 AGCCCGTAGGCAATTCAAA 
chHoxA10_seq_R2 AGTTTCATTCTGCGGTTCTGA 
chHoxA11_seq_F CCAACGTCTCCTCCAATTTCT 
chHoxA11_seq_R TGATATTTGGTGTAGGGGCATCT 
chHoxA13_seq_F TACATGGACACGTCGGTCTC 
chHoxA13_seq_R ACCTTTGTGTAGGGCACTCG 
chHoxD9_seq_F CGCCACTACGGGATAAAGC 
chHoxD10_seq_F CAGACGTCCCTTCCTACCAG 
chHoxD10_seq_R CAGGCAGCTCCTCTCGTCTT 
chHoxD11_seq_F CGCCTCCAACTTCTACGG 
chHoxD11_seq_R TTGAAGAAAAACTCACGTTCCA 
chHoxD12_seq_F GAGGAAAGATGCAGGCAGAG 
chHoxD12_seq_R TTCTTTCCTCTTCTGTCGGTTA 
chHoxD13_seq_F CATGGACGTCTCCAGTCTGA 
chHoxD13_seq_R GCTTGGTGTAGGGCACTCTC 
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chHoxA13_seq_F2 GAACTCGAAAGGGAATACGC 
chHoxA13_seq_R2 CATGTACTTGTCGGCGAAGG 
chHoxA13_seq_R3 CTCGCTCGACGTGTAGGC 
chHoxD11_seq_F2 GCAGTTGTCCAGAATGCTCA 
chHoxA9_seq_F2ex CAGGCTCCTCAACCTCACC 
chHoxA10_seq_F2ex GAGCGTCGCCTAGAGATCAG 
chHoxA11_seq_F2ex AACAAAGAGAAACGCCTCCA 
chHoxA13_seq_F2ex AGACAAACGGCGGAGGATA 
chHoxD9_seq_F2ex GAGCGAGGGAAAGAAAGGAA 
chHoxD10_seq_F2ex CGCGGCTAAAGTCTCTCAAG 
chHoxD11_seq_F2ex TGGAACGTGAGTTTTTCTTCAA 
chHoxD12_seq_F2ex CGAAAGAAACGGAAACCGTA 
chHoxD13_seq_F2ex GAGTGCCCTACACCAAGCTC 
chHoxD13seq_F3 CAGTGCCGTAACTTTCTCTC 
chHoxD13seq_F4 CTCTCCTCGCCCGTTTTC 
chHoxD13seq_R2 TCCTGGGTACATAGACATGG 
chHoxD13seq_R3 TTTGTATAGCCCTGGTAGGA 
chHoxD13seq_R4 CAACGGATACTATAGCTGCA 
ch_Hoxd13_R5 AGCCCGGGCAGTCCTTG 
ch_CTCF_Fnorm.   ATGGAAGGTGAAGCAGTTGAAGC 
ch_CTCF_Rnorm.    TCACCGGTCCATCATGCT 
ch_CTCF_F1_seq AGGCTACGGTGGATGATACG 
ch_CTCF_F2_seq CATTCCAGTGTGAACTGTGC 
ch_CTCF_F3_seq GCAGAAGCACACGGAGAAC 
ch_CTCF_F4_seq GAGACAAAGAAGGGCAAACG 
ch_CTCF_R1_seq GCTATATGGCAAGCCTCGTC 
ch_CTCF_R2_seq TTTGGCTGGTGGCTGATAGT 
ch_CTCF_R3_seq TGTGGCGTTTCAATTTGCTA 
RCAS_FLAG_F GCCGACCACCATGTCTGAC 
RCAS 5´seq TCCATCAGCTACCACACGGAA 
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3.1.7 Kits 
All below listed kits were used according to manufacturer’s recommendation. 
Table 3.6 Molecular Biology Kits 
Kit name Supplier 
NucleoSpin Plasmid Macherey-Nagel 
Nucleobond PC100 Macherey-Nagel 
Nucleobond PC100 EF Macherey-Nagel 
NucleoSpin Gel and PCR Clean-up Macherey-Nagel 
AllPrep DNA/RNA/Protein Qiagen 
SuperScript III First-Strand Synthesis System Thermo Fischer Scientific 
BigDye Terminator v3.1 Sequencing  Applied Biosystems 
QIAquick PCR Purification  Qiagen 
Vectastain IgG Mouse ABC  Biozol  
Peroxidase Substrate Kit DAB SK-4100 Vector Laboratories 
Duolink In Situ Red Starter Kit Mouse/Rabbit Sigma-Aldrich  
Gibson Assembly MasterMix New England Biolabs 
3.1.8 Vectors 
Table 3.7 Vectors  
Name Supplier 
pSLAX13-5’FLAG Dr. Jochen Hecht (Berlin) 
pSLAX13-5’HA Dr. Jochen Hecht (Berlin) 
RCASBP(A) Dr. Jochen Hecht (Berlin) 
RCASBP(B) Dr. Jochen Hecht (Berlin) 
3.1.9 Bacterial Strains 
Cloning steps were performed with an in-house E. coli Top10 (A.C. Stiege) strain.  
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3.1.10 Cell Culture Lines 
DF1 cell line originating from chicken fibroblast was obtained from ATCC. 
3.1.11 Animals  
Fertilized eggs (Clean Eggs quality) for chicken micromass cultures were purchased from VALO 
BioMedia GmbH (Osterholz-Scharmbeck). 
3.1.12 Instruments 
Table 3.8 Instruments  
Instrument Model No. / Type Supplier 
Table Top centrifuge 5414D  Eppendorf 
Chilling centrifuge 5417R Eppendorf 
Microtiter plate centrifuge 5416 Eppendorf 
Chilling centrifuge Avanti J-E Beckman-Coulter 
Rotor JLA16250 Beckman-Coulter 
Ultracentrifuge L7-55 Beckman 
Ultracentrifuge Rotor SW 32-Ti Beckman 
Thermocycler 
GeneAmp PCR System 
2700, 2720 and 9700 
Applied Biosystems 
Stereomicroscope MZ7-5 Leica 
Camera Axiocam MRc5 Zeiss 
Light source KL1500 LCD Leica 
Software Axiovision 4.x Zeiss 
Confocal microscope LSM700 Zeiss 
Sequencer  Genome Analyzer IIX  Illumina  
Cluster Station   Illumina 
Sonicator  BioRuptor NextGen UCD-300  Diagenode  
Photometer  NanoDrop 2000  Thermo Scientific  
Microplate Reader  Spectra Max 250  Molecular Devices  
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3.1.13 Software 
General and General Biological Software 
Cloning was performed in silico with CloneManager. Sequencing results were aligned and analyzed 
with DNA Star Sequman software. Reference sequences were taken from PubMed. UCSC 
Genome Browser was used for visualization of ChIP-seq and RNA-seq data. Digital pictures 
were edited using Carl Zeiss Axiovision 4.8.2 and CorelDRAW Graphics Suite. Figures were 
composed using Inkscape 0.48. The bibliography was managed using Mendeley. 
Bioinformatics Software for Analysis of ChIP-seq and RNA-Seq 
Table 3.9 Specialized Bioinformatics Software  
Software Task Source 
FastQC  Quality Control fastq-sequencing files  
http://www.bioinformatics.bab
raham.ac.uk/projects/fastqc/  
BWA Aligner  Aligning NGS-sequenced reads to reference genome  (Li and Durbin, 2009) 
SAM-Tools  Handling of SAM-files  (Li et al., 2009) 
Centrimo  Central enrichment of motifs  (Bailey and MacHanick, 2012)  
FIMO Quantification of motifs in peaks (Grant, Bailey and Noble, 2011) 
TOMTOM Identification of similar motifs in database (Gupta et al., 2007) 
SPP  Quality Control of ChIP-enrichment  
(Kharchenko, Tolstorukov and 
Park, 2008) 
BED-Tools  Handling of BED-files  (Quinlan and Hall, 2010) 
MACS2  Detection of ChIP-enriched regions  (Zhang et al., 2008) 
IDR  Reproducibility of ChIP-seq experiments  (Li et al., 2011; Landt et al., 2012) 
seqMINER  Read distribution analysis of ChIP-seq datasets  (Ye et al., 2011)  
webPRANK Sequence homology clustering (Löytynoja and Goldman, 2010) 
STAR mapper Aligning NGS-sequenced reads to reference genome (Dobin et al., 2013) 
Deseq2 Identification of differentially regulated genes (Love, Huber and Anders, 2014) 
GOrilla Gene ontology (Eden et al., 2009) 
GREAT Gene ontology (McLean et al., 2010) 
RStudio Used for PCA and diff. reg. gene clustering https://www.r-project.org/ 
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3.2 Methods 
3.2.1 Molecular Biological Methods 
All standard molecular biological procedures were performed according to (Sambrook & Russell 
(2001). 
3.2.1.1 DNA Isolation  
Plasmid-DNA isolation from Top 10 competent cells was performed using the Nucleospin or 
Nucleobond PC100 kits (Macherey-Nagel), according to the manufacturer’s instructions. 
Plasmid-DNA that was used for the cell transfection was always performed with Nucleobond 
PC100 EF kit. 
3.2.1.2 RNA Isolation 
RNA was isolated from the chMM cells using AllPrep DNA/RNA/Protein (Qiagen) according 
to manufacturer’s instructions. First, chMM were harvested as for ChIP-seq, and separated just 
before fixation (approx. 300 000 cells from every sample) for protein and RNA extraction. Cells 
were spun down, washed with 1x DPBS, and 600 RLTμL buffer (supplemented with 0.001% β-
mercaptoethanol) was added onto the cells. Extra RNase-Free DNase (Qiagen) treatment was 
added onto the columns to assure there is no DNA contamination, according to the 
manufacturer’s instructions.  
RNA from embryonic limbs at the HH25 was isolated the same way like RNA from the chMM 
cells with the additive step of tissue homogenization which was performed with a 0.5mm needle 
and a 1mL syringe. 
3.2.1.3 Protein Isolation 
Proteins were isolated from chMM cultures using the AllPrep DNA/RNA/Protein (Qiagen) kit 
according to manufacturer’s instructions. See Chapter 3.2.1.2 for the cell collection details. 
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3.2.1.4 Generation of cDNA  
cDNA synthesis for qRT-PCR was performed with the SuperScript III (Thermo Fischer 
Scientific) using 1μg of total RNA as template and oligodT primers. The reaction was conducted 
in 20μl volume. 
3.2.1.5 Polymerase Chain Reaction (PCR)  
Standard PCRs were performed according to (Sambrook and Russell, 2001). PCR reactions were 
performed using in-house Taq and Pfu polymerases produced by A.C. Stiege for colony PCR, 
and Phusion DNA-polymerase (NEB) or Deep Vent DNA-polymerase (NEB) for cloning of the 
HOX, HOXA10 deletion constructs, and CTCF. Additionally, PCR reaction of sequences with 
high GC content was supplemented with 1.5%-3% DMSO (Sigma-Aldrich).  
PCR for HOXA10 deletion constructs was performed with long-range buffer (Roche, 
#11681842001), and specific reaction conditions indicated below. 
  
Table 3.10 Reagents for the Amplification of HOXA10 Deletion Constructs 
Reagents Amount 
pSlax 3xFLAG-HOXA10 60ng 
Primer F (10 pmol/µl) 2µL 
Primer R (10 pmol/µl) 2µL 
dNTPs (10mM) 1.5µL 
DMSO 2.5µL 
Long Range Buffer 
(before use incubate 10 min at 56°C) 
5µL 
ddH2O to 50µL 
 
Table 3.11 PCR Machine Protocol for the Amplification of HOXA10 Deletion Constructs 
PCR machine protocol 
94°C                            3´                                                       ´                                                         
94°C                30´´ 
65°C (-1°C per cycle)              1´  10x 
68°C                9´(+30´´)                                           _          
94°C                30´´ 
58°C                1´  20x 
68°C                                   14´(+20´´)                                         _        
68°C                10´  
4°C                ∞ 
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3.2.1.6 Sanger Sequencing  
All PCR reactions for Sanger sequencing were performed with 80-100ng DNA as a template and 
BigDye v3.1 kit (Applied Biosystems), according to manufacturer’s instructions. If DNA 
template had a high amount of the GC content, 1.5-3%, DMSO was added to the PCR reaction. 
The product was cleaned with ethanol precipitation before it was sent for sequencing, which was 
carried out by Mohsen Karbasiyan (Charité) on an ABI3700 capillary sequencer. 
3.2.1.7 Cloning  
CDS regions of the genes listed in Table 3.12 were amplified with primers in Table 3.3 for every 
gene individually (except HOXD13, see below) from HH25 limb bud cDNA using standard PCR 
and Pfusion polymerase (NEB). Amplification of HOXA10 deletion constructs was carried out 
from a pSlax 5’-3xFLAG-HOXA10 template, as explained in the Chapter 3.2.1.5. 
Cloning of HOX Genes to pSLAX 
pSlax vector was previously modified to contain 3xFLAG-tag and just after restriction sites for 
NcoI and SpeI (done by A.C. Stiege and J. Hecht). Therefore, the NcoI and SpeI were used as a 
cloning strategy for nine HOX genes. Forward amplification primers for HOX genes were 
designed so that they contain a restriction site for an enzyme creating an overhang identical to 
NcoI because NcoI sites were present in all HOX CDS (Table 3.12). Reverse primers were 
designed so they contain a site for SpeI. Amplified HOX gene products and pSlax 5’-3xFLAG 
were digested with NcoI (or an appropriate alternative) and SpeI, cleaned with NucleoSpin Gel 
and PCR Clean-up (Macherey-Nagel) and ligated overnight. 
HOXD13 gene was especially difficult to verify by Sanger sequencing after amplification. 
Therefore a vector containing chicken HOXD13 CDS was purchased from AddGene (CT#441), 
amplified with primers stated in Table 3.3 and Deep Vent polymerase, and cloned into pSlax 5’-
3xFLAG as described above. 
Cloning of CTCF  Gene to pSLAX 
CTCF CDS region was amplified using primers designed for Gibson Assembly (Table 3.3). 
Then, the product was cleaned with NucleoSpin Gel and PCR Clean-up (Macherey-Nagel), and a 
Gibson Assembly was performed using Gibson Assembly MasterMix (NEB) with CTCF CDS 
and pSlax 5’-3xFLAG, or pSlax 5’-HA, following the manufacturer’s instructions.  
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Cloning of HOXA10 Deletion Constructs to pSlax 
HOXA10 deletion constructs primers (Table 3.4) were designed to have 5‘ phosphorylated 
overhang and to point either forward or reverse from the end points of the desired deletion. 
Then, pSlax 5’-3xFLAG-HOXA10 was used as a template for a long-range PCR as explained in 
the Chapter 3.2.1.5. Amplified pSlax 5’-3xFLAG-HOXA10 deletion constructs were then simply 
ligated as they contained phosphorylated overhangs. 
Cloning of HOX, CTCF and HOXA10 Deletion Constructs to RCASBP 
All constructs were cut from pSlax using ClaI and SpeI enzymes. This way tag sequence (3xFLAG 
or HA) was cut out together with the gene. At the same time, RCASBP(A) and RCASBP(B) were 
digested with ClaI and SpeI. Then, genes were ligated to the appropriate RCAS vector using 
standard overnight ligation. 
Table 3.12 Reference Sequences  
Sequence name NCBI Reference Sequence Enzymes used for cloning to pSlax 
HOXA9 XM_003640734.1 Esp3I and SpeI 
HOXA10 XM_001235692.1 Esp3I and SpeI 
HOXA11 NM_204619.1 BspHI and SpeI 
HOXA13 NM_204139.1 PciI and SpeI 
HOXD9 XM_001234506.2 BspHI and SpeI 
HOXD10 XM_001234538.2 PciI and SpeI 
HOXD11 NM_204620.1 BspHI and SpeI 
HOXD12 NM_205249.1 Esp3I and SpeI 
HOXD13 As purchased in plasmid BpiI and SpeI 
CTCF NM_205332.4 Gibson Assembly cloning 
 
3.3 Cell Culture Methods  
3.3.1.1 Cultivation of DF1 cells  
DF1 cells were thawed from the liquid N2 stock, spun down to get rid of the DMSO and plated 
to 75cm2 flask in the DF1 Standard. Cells were split 1:10 upon confluency and not kept in the 
culture past passage 50. 
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Table 3.13 DF1 Cultivating media 
Media  Composition 
DF1 Standard 
DMEM, 4.5g/L Glucose; 10% FCS Superior (Biochrom, #S0615/0411A); 2% chicken 
serum (Gibco, #16110-082); 1% L-glutamine (Lonza, #17-605E); 1% penicilin-
streptomycin (Biochrom, #A2213) 
DF1 Starvation 
DMEM, 1g/L Glucose; 1% FCS Superior (Biochrom, #S0615/0411A); 0.2% chicken 
serum (Gibco, #16110-082); 1% L-glutamine (Lonza, #17-605E); 1% penicilin-
streptomycin (Biochrom, #A2213) 
 
3.3.1.2 Virus Preparation  
Virus preparation was performed as in Seemann (2006) with few modifications at the DF1 
transfection step. 
DF1 cells were grown on the two 10cm plates until confluency reached 80%. Transfection was 
performed in every plate as follows: 7µg of RCASBP DNA and 250µL 150mM NaCl were added 
to the first tube and mixed vigorously; 46.5µL of PEI (Polyscience, #24765-2) and 625µL of 
150mM NaCl were added to a second tube and mixed vigorously. Then, contents of two tubes 
were combined, mixed vigorously, and incubated under the cell culture hood for 30 min. 
Thereupon, transfection mix was added to cells with a pipette.  
3.3.1.3 Chicken Micromass (chMM)  
Original chicken micromass protocol DeLise et al. (2000) was adapted by Seemann (2006).  
Here, fresh, fertilized eggs were incubated for 4.5 days (to reach HH24-25 stage) at the 37.5°C 
and >60% humidity. After that, the eggs were opened and embryonic fore- and hindlimbs 
harvested and collected in PBS.  
Then, limbs were washed 3-5 times with pre-warmed HBSS (Hanks’ Balanced Salt Solution, 
Cambrex, #BE10-547F) solution. Limbs were digested with 300µL dispase solution (Gibco, 
#17105-041, 3 mg/ml in HBSS) for 15 minutes with gentle shaking every few minutes, to detach 
ectoderm. Limb buds were, then, washed 5-6 times with pre-warmed HBSS to ensure the near 
complete removal of the ectodermal layer. Then, limb buds were incubated for 30 min in 1mL 
pre-warmed digestion solution (0.1% (w/v) Collagenase type Ia (Sigma-Aldrich, #C9891), 0,1% 
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(w/v) trypsin (Gibco), 5% FBS in PBS) to detach the cells from one another. To ensure this 
19mL of pre-warmed chMM media (DMEM Ham‘s F-12 (1:1) ; 1% FCS Superior (Biochrom, 
#S0615/0411A); 0.2% chicken serum (Gibco, #16110-082); 1% L-glutamine (Lonza, #17-605E); 
1% penicillin-streptomycin (Biochrom, #A2213) ) was addedto cells and passed through a cell 
strainer. Cells were then counted (Neubauer cell chamber), spun down, and adjusted in pre-
warmed chMM media to a 2x107 cells/mL cell suspension density. 
Finally, cell suspension was split into aliquots, infected with an appropriate virus (virus-to-cell 
ratio 2 :1) and seeded in a 24-well plate in 10μL per well central droplets. Cells were left to attach 
to the plate for 2h at 37°C, and then 1mL of warm chMM media was carefully added to the 
cultures. chMM media was changed every two days and cultures were harvested for ChIP-seq, 
RNA-seq, and protein analysis six days post infection. 
Staining of chMM Cultures 
Individual chMM cultures were stained with Alcian Blue and Eosin every three days, until day 15, 
to assess differentiation process and impact of the overexpressing TFs onto this process. 
For Alcian Blue, cultures were fixed for 1h at room temperature or 4°C overnight with Kahles 
Fixative (30%EtOH, 0.4%PFA, 4% acetic acid) and stained with After Eight Blue stain (0.05% 
Alcian Blue in 0.1M HCl-solution) overnight at room temperature. Then, cultures were washed 
with PBS, photographed with no liquid, left to dry, and destained overnight with 6M Guanidin 
Hydrochloride. Blue staining of chMM was then quantified on 592nm wavelength on ELISA 
plate reader. 
For Eosin, cultures were fixed with 4% PFA in PBS at 4°C overnight. They were washed with 
PBS and stained with eosin for 60-90 sec. Cultures were photographed immediately after staining 
with no liquid in the well to prevent quick de-staining of Eosin. 
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3.4 Biochemical Methods  
3.4.1 Determination of Protein Concentration  
Protein concentration was measured using Bradford Assay (Roth) according to manufacturer’s 
instructions. Absorption was measured at the 592nm wavelength on an ELISA plate reader. 
Proteins were then compared to known BSA dilution series and quantified. 
3.4.2 SDS-PAGE 
Protein gel electrophoresis (SDS_PAGE) was performed on 13.5% polyacrylamide gels as in 
(Sambrook and Russell, 2001) 
3.4.3 Western Blot (WB) 
Western blots were carried out according to standard procedures as in Sambrook & Russell 
(2001). Protein transfer was performed in a tank using PVDF membrane (Millipore Immobilon-
P, 0.45μm pore size) and a pre-cooled transfer buffer (25mM Tris-Base; 200mM Glycine, 20% 
Methanol) at 4°C and 20V overnight. 
Membrane was blocked with 3% BSA (Sigma-Aldrich) in TBS-T (0.1% Tween-20) for 1h. Then, 
primary antibody was incubated in the blocking solution at 1:1000 for 1h at room temperature. 
Membrane was washed with TBS-T three times for 10min at room temperature, and then 
secondary antibody was diluted in blocking solution at 1:1000 and incubated for 1h at room 
temperature. Finally, three TBS-T 10min washing steps were performed and the signal was 
detected using Western Lightning Plus-ECL (Perkin-Elmer) and various X-Ray films, developed 
on the AGFA Curix 60. 
3.4.4 Co-Immunoprecipitation (co-IP) 
Co-immunoprecipitation was performed following an adapted Andrews & Faller (1991) nuclear 
lysate co-IP protocol. 
Cell Harvesting and Nuclear Extraction 
First, DF1 cells were cotransfected with RCASBP(A)-5’-3xFLAG-HOXA10, RCASBP(A)-5’-
3xFLAG-HOXD13, or any of seven RCASBP(A)-5’-3xFLAG-HOXA10 deletion constructs and 
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RCASBP(B)-5’-HA-CTCF following standard transfection protocol as explained in Chapter 
3.3.1.2. Cells were cultured with DF1 standard medium for six days, trypsinized (Gibco), 
resuspended in 1.5mL ice-cold DPBS and spun down for exactly 10sec on table top centrifuge. 
Supernatant was discarded, and resuspended in 400µL ice-cold Low-salt buffer (with freshly 
added Roche protease inhibitor) and incubated for 10min on ice. Cells were then vortexed for 
10sec and briefly spun down on the table top centrifuge. Pellet was resuspended in 100µL ice-
cold High-salt buffer (with freshly added Roche protease inhibitor) and incubated on ice for 20 
min. Finally, nuclei were pelleted for 2min at 13 000 rpm at 4°C, and supernatant was transferred 
to a new tube and stored at -80°C. 
Immunoprecipitation 
25µL of magnetic Protein G (Invitrogen) beads were washed with 500µL of Blocking buffer 
three times. Afterward, 200µL of Blocking buffer was added to the blocked beads and, either, 
5µL of αHA (BioLegends) or IgG control (Cell Signalling Technologies). The beads-antibody mix 
was incubated 3h at 4°C. Beads were washed three times with 300µL of BS3 Conjugation Buffer 
and then incubated with 250µL of BS3 Working solution at room temperature for 30 minutes on 
a rolling machine. The reaction was quenched with 12.5µL of Quenching buffer for 15 minutes at 
room temperature on a rolling machine. Beads were then washed two times with 500µL of cold 
IP buffer (with freshly added Roche protease inhibitor). 
Next, the sample was added and diluted to 250µL with the IP buffer (with freshly added Roche 
protease inhibitor), and samples were incubated at 4°C overnight with rolling. Next day, the 
samples were washed two times with 1mL Wash buffer 105 (with freshly added Roche protease 
inhibitor) and three times with Wash buffer 150 (with freshly added Roche protease inhibitor) 
and then eluted with 30µL co-IP elution buffer for 15min at room temperature with rolling. 
Beads were then spun down at 13 000 rpm for 1min, and the supernatant was stored at -80°C. 
Immunodetection 
Eluted samples were then loaded on an SDS-PAGE gel, and subsequently, Western blot was 
performed using αFLAG antibody (Sigma-Aldrich) as described in the chapter Chapter 3.4.2 and 
Chapter 3.4.3. 
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3.5 Proximity Ligation Assay (PLA) 
PLA was performed using Duolink In Situ Red Starter Kit Mouse/Rabbit (Sigma-Aldrich) according 
to manufacturer’s instructions with some in-house solutions. 
First, DF1 cells were transfected as shown in Chapter 3.3.1.2 and cultured for six days. Then, 
they were re-plated to 24-well plate with coverslips to optimize the surface area for the PLA. 
Next day, cells were fixed with 4% PFA in PBS for 11min and washed three times with 1x PBS. 
Cells were blocked with an in-house PLA Blocking solution for 1h at room temperature. Then, 
primary antibodies αHA (BioLegends), αRAD21 (Abcam), αCTCF (Active Motif), and αFLAG 
(Sigma-Aldrich) were diluted with an in-house PLA antibody diluent and 200µL this dilution was 
added to cells. Antibody dilutions were then applied to cells (as in Table 3.14) and incubated for 
1h at 4°C. Afterward; slides were washed two times 5min with 10% horse serum in TBS-T (0.2% 
Tween).  
PLUS and MINUS probes (Duolink kit,secondary antibodies labeled with oligos) were diluted 1:5 
with PLA antibody diluent and incubated at room temperature for 20min. Diluted PLUS and 
MINUS probes were added to cells and incubated in a pre-heated humidity chamber at 37°C for 
1h. Cells were, then, washed two times 5min with 1x PLA buffer A.  
Ligation stock (Duolink kit) was diluted 1:5 with ddH2O and ligase was added last in 1:40 ratio. 
40µ of the ligation reaction was added to cells and then incubated in a pre-heated humidity 
chamber at 37°C for 30min. Cells were then, washed two times 2min with 1 x PLA buffer A.  
Then, polymerase chain reaction was performed with fluorescently labelled nucleotides. First, 
Amplification stock (Duolink kit) was diluted 1:5 in ddH2O and polymerase was added last in 
1:80 ratio. Then, 40µL of diluted Amplification solution was applied to the cells and incubated 
for 100min in the preheated humidity chamber at 37°C. Cells were washed two times 10min with 
1x PLA buffer B and once 1min with 0.01x PLA buffer B. All reactions from Amplification on 
were performed in the dark. 
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Table 3.14 PLA Experimental Setup, Antibodies, and Antibody Dilutions 
 Transfection combinations Desired detection Antibodies used and dilutions 
P
o
si
ti
v
e 
co
n
tr
o
l 
RCASBP(B)-5’-HA-CTCF CTCF-RAD21 
rb αRAD21 (Abcam) 1:1 000 
m αHA (BioLegends) 1:8 000 
D
e-
no
vo
 
in
te
ra
ct
io
n
s 
RCASBP(A)-5’-3xFLAG-
HOXA10 
 
HOXA10-CTCF 
m αFLAG (Sigma-Aldrich) 1:20 000 
rb αCTCF (Active Motif) 1:20 000 
RCASBP(A)-5’-3xFLAG-
HOXD13 
 
HOXD13-CTCF 
m αFLAG (Sigma-Aldrich) 1:20 000 
rb αCTCF (Active Motif) 1:20 000 
RCASBP(A)-5’-3xFLAG-
HOXA10 deletion constructs 
 
HOXA10Δ-CTCF 
m αFLAG (Sigma-Aldrich) 1:20 000 
rb αCTCF (Active Motif) 1:20 000 
N
eg
at
iv
e 
co
n
tr
o
l 
  
m αFLAG (Sigma-Aldrich) 1:20 000 
rb αCTCF (Active Motif) 1:20 000 
 
3.6 Chromatin Immunoprecipitation 
Chromatin Immunoprecipitation (ChIP) is a technique that allows for identification of protein-
DNA interactions. It is a week-long, multi-step protocol where a specific antibody is directed 
against a TFs, histones, histone modifications, or any other protein binding to DNA (e.g. RNA 
Pol II). Results of chromatin immunoprecipitation can be analysed on qRT-PCR or by next 
generation sequencing (NGS), which offers a genome-wide profile for protein binding. Here, 
ChIP was accompanied with NGS sequencing to study nine paralogous HOX-TFs, to determine 
and compare their DNA binding. 
3.6.1 Chromatin Preparation 
Here used ChIP protocol is a  Lee et al. (2006) ChIP protocol modified by Ibrahim (2014) and 
subsequently by I.Jerković. 
Cell Harvesting and Fixation 
After six days of culture, chMM cultures were taken out of the culture, and the media was 
aspirated. Then, 200µL of collagenase solution (0.1% (w/v) Collagenase type Ia (Sigma-Aldrich, 
Cat.-No. C9891) in chMM-medium) was added to every well of the 24-well plate and incubated at 
37°C for 30-90min. This incubation was followed by disruption by pipetting which allowed easier 
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detachment of chMM cultures from wells and easier disruption of a very dense clump of cells 
building the chMM culture. Harvested cultures were collected in a Falcon tube, pelleted for 5min 
at 1 000 rpm at 4°C, and pellet was resuspended in 10mL of cold chMM medium. Usually, 3-4 
plates were used per replicate. 
Cells were then crosslinked with 273.5µL of 37% formaldehyde (Roth) (1% final concentration) 
and incubated for 10min on ice with occasional turning the tube. As this is an important step, the 
fixation time was always rigorously controlled to achieve better comparability between the 
samples. If cells get fixed too strong it might induce a GC bias in the NGS, whereas if they are 
under fixed there will be many positive interactions lost as they won’t be cross-linked efficiently. 
Therefore, after exactly 10min 550µL of 2.5M glycine in PBS (0.125M final concentration) was 
added and the tubes and inverted several times to quench the formaldehyde efficiently. After that, 
cells were washed twice with 1x PBS and cells were snap-frozen in liquid N2 and stored at -80°C. 
Cell Lysis and Nuclear Extraction 
Pelleted cells were taken out of the -80°C, thawed on ice, resuspended in 10mL of ice-cold Lysis 
buffer 1 (with freshly added Roche protease inhibitor), and incubated for 10min at 4°C, with 
rocking. Then, cells were spun down (5min at 2700xg) at 4°C and supernatant discarded. Pellet 
was resuspended in 10mL of Lysis buffer 2 (with freshly added Roche protease inhibitor) 
followed by 10min incubation at room temperature with rocking. Cells (at this point already 
nuclei) were spun down again (5min at 2700xg), the supernatant discarded, and the pellet was 
resuspended in 1.5mL of ice-cold Lysis buffer 3 (with freshly added Roche protease inhibitor). 
Sonication 
Then, cells/nuclei were sonicated on the Bioruptor NextGen for 35 to 45 cycles (30seconds 
pulse, 30seconds pause) making sure that the water bath was cool entire time of sonication 
duration to prevent overheating of the samples. 
Finally, samples were cleaned up from cellular debris by the addition of 10% Triton-X-100 (to 
1% end concentration). Samples were, then, centrifugated at 16 000xg for 15min at 4°C and 
supernatant was transferred to a new tube. 5-10% of the sample volume was taken for the 
sonication quality control, and rest of the sample was stored at -80°C. 
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Sonication Control 
Sample aliquot separated after sonication was used to assess quality of the sonicated chromatin. 
For this, 4µL of Proteinase K (20mg/mL) and 5M NaCl in final concentration of 10% was added 
to sonicated chromatin. Everything was then mixed and incubated at 65°C overnight. Next day, 
4µL of RNaseA (5mg/mL) was added to de-crosslinked chromatin and incubated 30min at 37°C. 
DNA was, then, purified by ethanol precipitation and dissolved in 20µL ddH2O. After that, 
DNA concentration was measured on Nanodrop to determine chromatin concentration, and the 
rest 19µL were loaded on a 1% agarose gel to investigate sonication efficiency (successful 
sonication smear appears between 200-500 bp size). 
Chromatin concentration was determined using the following formula: 
𝑐 (
𝑐ℎ𝑟𝑜𝑚𝑎𝑡𝑖𝑛 
𝑛𝑔/µ𝐿
) =
𝑐 (
𝐶ℎ𝑟𝑜𝑚𝑎𝑡𝑖𝑛 𝑓𝑜𝑟 𝑠𝑜𝑛𝑖𝑐𝑎𝑡𝑖𝑜𝑛 𝑐𝑜𝑛𝑡𝑟𝑜𝑙
𝑎𝑠 𝑚𝑒𝑎𝑠𝑢𝑟𝑒𝑑 𝑜𝑛 𝑛𝑎𝑛𝑜𝑑𝑟𝑜𝑝
) ∗ 𝑉 (
𝐶ℎ𝑟𝑜𝑚𝑎𝑡𝑖𝑛 𝑓𝑜𝑟 
𝑠𝑜𝑛𝑖𝑐𝑎𝑡𝑖𝑜𝑛 𝑐𝑜𝑛𝑡𝑟𝑜𝑙
)
𝑉(𝑡𝑜𝑡𝑎𝑙 𝑐ℎ𝑟𝑜𝑚𝑎𝑡𝑖𝑛 𝑎𝑓𝑡𝑒𝑟 𝑠𝑜𝑛𝑖𝑐𝑎𝑡𝑖𝑜𝑛)
 
 
3.6.2 Immunoprecipitation 
Beads-antibody Preparation 
First, 35µL of Protein G beads were washed three times with 1mL of 0.5% BSA in DPBS to 
block the beads. Then, 8µL of the αFLAG (Sigma-Aldrich), 8µL of αRAD21 (Abcam), 2.5µL of 
αH3K4me3 (Millipore), or 2.5µL of αH3K27me3 (Millipore) was diluted in 300µL of 0.5% BSA-
DPBS. Antibody dilutions were added to blocked beads and incubated overnight at 4°C with 
rotation. 
Immunoprecipitation 
Next day, beads were washed with ice-cold Lysis buffer 3 (with freshly added Roche protease 
inhibitor), chromatin was added to beads-antibody mix, and volume was adjusted with Lysis 
buffer (with freshly added Roche protease inhibitor and Triton-X-100 (final concentration 1%)), 
to 1.2mL. If the ChIP was performed for TFs 35µg of chromatin was added to 
immunoprecipitation and if ChIP was performed for histone modifications 10-15µg of chromatin 
was used for immunoprecipitation. Samples were incubated overnight at 4°C with rotation. In 
parallel, 100µL of the non-IPed sonicated chromatin was taken as an input control and stored at -
20°C. 
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Following day, samples were washed seven times using ice-cold RIPA buffer (with freshly added 
Roche protease inhibitor) and once with ice-cold TE-NaCl (with freshly added Roche protease 
inhibitor) buffer on magnetic rack. Supernatant was discarded, and beads were centrifuged at 1 
000rpm at 4°C for 3min, and rest of the supernatant was carefully removed using the magnetic 
rack to prevent any carryover of beads.  
Elution, Crosslink-reversal, and Purification 
Proteins were then eluted by adding the 210µL of Elution buffer to beads and incubating them at 
65°C for 30min with vigorous shaking. Afterward, beads were spun down at 16 000xg for 1min 
at 4°C, and 200µL of the supernatant was transferred to a new tube.  
Then, the input chromatin was thawed and together with the ChIP’ed samples subjected to 
crosslink-reversal. For crosslink-reversal, first 4µL of Proteinase K (20mg/mL) and 5m NaCl to 
10% end concentration were added to each sample, mixed, and incubated at 65°C overnight. 
Next day, 4µl of RNaseA (5mg/mL) was added to each sample and incubated at 37°C for 30min.  
Finally, samples were purified using the standard Phenol-Chloroform method and precipitated 
with ethanol using 10% 3M Na-acetate and 4µL of glycogen (Ambion 5mg/ml, # AM9510) as a 
carrier. Precipitated samples were sent to the BCRT sequencing facility for further processing. 
Input and ChIP samples were sequenced on Illumina HiSeq in 50bp single-end reads. 
3.6.3 Quality Control and Initial Processing of ChIP-seq data 
ChIP performed in this study was used in combination with NGS to create genome-wide binding 
HOX maps. Since the ChIP-seq initial output generates millions of sequencing reads, it was 
necessary to perform comprehensive and complete quality control on individual samples, and 
reproducibility controls on biological replicates. Sequenced reads were enriched for fragments 
that come from the immunoprecipitated DNA, therefore allowing for the visualization of these 
enrichment points, called peaks. In order to determine if sample was of good quality, peak-to-
background ration had to be high, and to determine reproducibility between samples peaks had 
to always occur at the same positions. Roughly, these two issues are focal points of ChIP-seq 
quality analysis and will be discussed in more detail in subsequent chapters. Initial control analysis 
and reproducibility testing were performed according to the ENCODE guidelines for ChIP-seq 
(Li et al., 2011; Landt et al., 2012).  
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ENCODE guidelines were followed closely, and all the necessary tools to run this pipeline were 
available on the locally installed GALAXY platform at the Charitè (Blankenberg et al., 2010; 
Goecks et al., 2010). This local GALAXY platform was installed and moderated by Peter Hansen, 
and the ENCODE pipeline was designed and implemented by Peter Hansen and Daniel M 
Ibrahim. 
Quality Control and Read Mapping 
First step in the assessment of a ChIP-seq sample is the quality control of raw sequences. This 
was assessed with the FastQC program (Filter-by-Quality function (FASTX-toolkit)) which 
allowed all the reads that did not score well enough (if average Phred-score < 28) to be discarded. 
Rest of the sequences were then mapped to chicken genome (galGal4) with the BWA aligner 
using following parameters (aln -n=0, aln -o=1, aln -e=1, aln -d=16, aln -i=5, aln -l=-1, aln -k=2, 
aln -M=3, aln -O=11, aln -E=4, aln -R=FALSE, aln –N=FALSE, samse/sampe –n=3, sampe=–
N10, sampe –a=500, sampe –o=100000, samse/sampe –r=NO). BWA aligner created an output 
.sam file with mapped reads. .sam file was, then, used to remove the reads that map ambiguously 
in the genome (e.g. repetitive regions) by selecting lines matching XT:A:U, @SQ, or @PG 
(XT:A:U- a .sam tag that marks uniquely mapped reads, @SG, and @PG are comment lines). 
Then, a .bam file was created and PCR artifacts (introduces during the library preparation) were 
removed with rmdup function (SAMtools). 
Once all poor quality, ambiguous, and redundant reads were kicked out, filtered .bam file was 
subjected to quality of enrichment analysis. This was assessed using cross-correlation analysis of 
the spp 1.11 package (get-binding characteristics function, parameters: -srange=0,1000; -bin=5; -
cluster=2; -debug=F; -MinTagCount=1000; -Acceptance_Z_Score=3; -
RemoveTagAnomalies=T; -Anomalies_Z=5; -AcceptAllTags=F).  
ENCODE guidelines suggest different quality thresholds, however not all thresholds have to be 
met by every experiment. Most relevant thresholds are the sequencing depth, NRF, NSC, and 
RSC. Sequencing depth was aimed to reach at least 10 000 000 non-redundant reads per 
biological replicate. This enables the recovery of almost all binding sites in the genome. NRF 
(non-redundancy fraction) compares the ratio of redundant (PCR artifact) and non-redundant 
reads, giving information about the library complexity. NSC (normalized strand coefficient) and 
RSC(relative strand coefficient) and two parameters that provide an approximation of enrichment 
in the ChIP. However, these two metrics can also be influenced by the biological properties of 
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investigated TFs. Some ChIP-seq data scored marginally on this analysis. This is further discussed 
in Chapter 4.5.1 and Chapter 5.2.1. 
Reproducibility Analysis 
After initial and quality control of individual samples, it is essential to address reproducibility 
between the samples. This was performed according to the ENCODE guidelines with the 
Irreproducibility Discovery Rate analysis (IDR) (Li et al., 2011). 
IDR is used for two main purposes. First, IDR analysis compares similarity between two samples. 
It takes two ranked lists of peaks (containing both true peaks and false peaks) and compares 
them. IDR assumes that the higher the peak is, the more reproducible it should be. By using true 
positive and false positive the IDR can discriminate between groups.Second, IDR analysis helps 
determine the threshold for the reproducible peaks. 
Peak Calling 
In order to call reproducible peaks from a ChIP-seq experiment, an IDR analysis has to be run 
first. For this, it is necessary to call peaks with low stringency. This is done with MACS2 
(parameters: -g 1.0e9, –p 1e-1, --too-large, --bw (as determined by spp in the quality control 
step)). MACS2 calls a huge number of peaks (300 000 or more) most of which are not true peaks. 
For IDR analysis, peak lists are truncated to 120 000 and ranked according to the p-value to 
inform of the peak strength. To compare the reproducibility between two biological replicates 
peaks have to be called for eight datasets.  Peaks are called on two biological replicates to check 
for the replicate consistency. Furthermore, peaks are called for pseudoreplicates2 for each of the two 
biological replicates to check for self-consistency, and on a pooled sample to check pooled-sample 
reproducibility. 
Self-consistency 
(pseudoreplicates) 
Rreplicate  
consistency 
Pooled  
consistency 
Rep1.1 
Rep1.2 
Rep1 Rep0.1 
Rep2.1 
Rep2.2 
Rep2 Rep0.2 
 
 
                                                 
2 Pseudoreplicates are randomly selected reads from the parent .bam file (e.g. Rep1 .bam reads are randomly selected 
and distributed to two new .bam files creating pseudoreplicates Rep1.1 and Rep1.2). 
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Irreproducibility Discovery Rate (IDR) 
IDR was performed for every of the eight peak lists effectively checking the self-consistency, replicate 
consistency, and pooled-consistency. 
IDR informs which number of peaks are reproducible above a certain threshold. For example, a 
number of peaks determined for the pooled-sample above the 0.01 threshold means that 99% of 
the peaks under that threshold is reproducible. For replicate consistency and self-consistency IDR 
thresholds of 0.01 were used for pooled-consistency 0.0025, except for the HOXA13. For the 
HOXA13 we used a “rescue strategy”, as suggested by ENCODE, using reproducible peak 
number from 0.01 threshold from pooled-consistency. This was chosen because second biological 
replicate of HOXA13ChIP-seq had same binding profile like the first biological replicate, but 
lower signal-to-noise ratio.  
Final Peak Sets 
To determine final peak sets, peaks were called using MACS2 with low stringency. This set of 
peaks was then sorted on the p-value. From this ranked list, peak number was determined by the 
replicate consistency 0.01 threshold, and top confidence peaks were selected. This was adjusted to 
pooled-consistency 0.01 threshold for the HOXA13 peaks. 
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3.7 Bioinformatics Analyses 
3.7.1 Motif Analysis 
3.7.1.1 De novo motif analysis 
Peak summits were extended +/-75bp around the summit using bedtools (getfasta -name -s –fi 
galGal4genome.fa -bed input.bed -fo output.fa). Extended fasta files were used as an input for 
RSAT tool (Thomas-Chollier et al., 2012) where fast and efficient, de-novo motif analysis was 
performed using default parameters. Oligomer length selected was set to 7. 
3.7.1.2 Peak Overlap & Peaks in Regions 
Peak Overlaps 
Peak summit .bed files were extended +/-150bp around the summit. Then bedtools (intersect -a 
A.bed -b B.bed -f 0.33222591362126245847176079734219 -u -wa >AoverlapB.bed) were used to 
determine overlaps between two peaks. Two peak summits had to be no further than 200bp apart 
to be considered as overlapping.  
Overlaps were performed in the following manner. First, top 10 000 peaks from the dataset A 
were investigated for overlaps with entire dataset B. Then, top 10 000 peaks from dataset B were 
investigated for overlaps with entire dataset A (see Chapter 4.5.2). This was done to accomplish 
better comparability between the samples.  
Peaks in Regions 
galGal4 genome was partitioned into “regions”: introns, exons, promoters (-5kb up to 2kb 
around TSS), and intergenic (the rest of the genome not attributed by aforementioned three) 
regions. Then overlaps between peaks and “regions” were obtained as described in Peak 
Overlaps above.  
3.7.1.3 MEME Analyses 
Centrimo 
Peak summits were extended +/-250bp around the summit and .fasta file was produced, as 
explained in Chapter 3.7.1.1. Centrimo analysis was performed using default parameters (Bailey 
and MacHanick, 2012). 
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FIMO 
Peak summits were extended +/-150bp around the summit and .fasta file was produced, as 
explained in Chapter 3.7.1.1. Peaks were then screened for the individual uploaded motifs using 
default parameters (Grant, Bailey and Noble, 2011). For the motif count, it was made sure peaks 
were counted only once if carrying more than one motif. 
TOMTOM 
TOMTOM was used for the comparison of the A9-PBX1 compact motif, AP1, “Unmatched”, 
and CTCF motif comparisons using default parameters (Gupta et al., 2007). 
3.7.2 seqMINER 
seqMINER was used to generate overlaps between peaks (HOX and CTCF) and genome-wide 
binding profiles (histones). Parameters were set as follows, 5 clusters, KMeans seed 3150032, +/-
5kb window, and KMeans linear clustering normalization for multiple datasets (Ye et al., 2011).   
3.7.3 Principal Component Analysis (PCA) 
galGal4 genome was partitioned in 500bp windows and then overlapped with the peak summits. 
This created a binary table that was made into a matrix (with mat_data). PCA was performed 
using FactoMineR R package.  
3.7.4 Vista Enhancer Clustering 
Vista enhancer clustering was performed using same logic like in the Chapter 3.7.3. Binding was 
examined in every enhancer region, and a binary table was created. Later this table was made into 
a matrix (with mat_data) and clustered in R using heatmap2. 
3.7.5 RNA-seq 
RNA-Seq mapping and differential gene expression were performed using a pipeline created for 
RG Mundlos by Dr. Stefan Haas.  
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Mapping and Annotation of RNA-Seq data (with the S.Haas pipeline) 
RNA-seq reads were mapped to galGal4 genome using STAR mapper (Dobin et al., 2013). Splice 
junctions were based on RefSeq/ENSEMBL combined gene annotations options included: 
alignIntronMin 20, alignIntronMax 500000, outFilterMultimapNmax 5, outFilterMismatchNmax 
10, and—outFilterMismatchNoverLmax 0.1). RefSeq (galGa4) and ENSEMBL (release 75) gene 
annotations were combined to generate read counts for the individual gene.. 
Generation of Differentially Regulated Genes (with S. Haas pipeline) 
Differential expression of genes was generated using DEseq2 comparing either a HOX 
overexpression and control or two HOX paralogue count files (Love, Huber and Anders, 2014). 
Top 50 differentially regulated genes were identified with DEseq2 (top-value < 10−5,minimum 
base mean >30, and a fold change >2) and clustered with R heatmap3 (log2 transformed changes 
(compared to control) were used as R input). 
Gene Ontology Analysis 
For GOrilla analysis gene names were used as input. Gene names were lifted over to mm9 gene 
names using Orthoretriever (UCSF, 2015). For a background all mm9 genes were used. GOrilla 
was used with default parameters (Eden et al., 2009). 
For GREAT analysis only genomic coordinates can be used. Genomic locations were retrieved 
using Orthoretriever and isolating the genomic coordinated from the output. GREAT was used 
with default parameters(McLean et al., 2010). 
Estimation of Viral Expression Levels Dr. Stefan Haas and Dr. Daniel M Ibrahim 
RCAS codes for a polycistronic mRNA where only one-third of all transcripts contributes to the 
production of a HOX protein. To address this issue, all splice variants that could be 
unambiguously identified were counted and a ratio (“HOX factor”) of the HOX splice variant 
was produced for every HOX. Then, HOX RPKM values were multiplied by its own “HOX 
factor” producing the real RPKM values. 
In parallel, RPKM for all nine HOX  genes from HH23 posterior, distal forelimb was calculated. 
In this tissue, nine HOX are at least partially expressed (see Chapter 4.3). Then, the chMM 
RPKM was simply divided by the forelimb RPKM, and the overexpression fold was generated. 
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4  Results  
4.1 Investigation of Posterior HOXA/D Protein Homology 
Hox genes have emerged from a single ancestor through series of tandem and whole genome 
duplications. As Hox gene number increased, it was hypothesized that the evolutionary pressure 
temporarily reduced creating a “window of evolvability” (Wagner, Amemiya and Ruddle, 2003). 
These newly duplicated genes could then adopt new role and expression during embryogenesis 
and allow for the morphogenesis of new organs and structures. This novel role would emerge 
through the change in the cis-regulatory elements or the changes in the gene body. The changes in 
the gene body inherently affect its protein product and the protein function, possibly affecting 
the Homeodomain and the protein-DNA binding.  
Therefore, I first examined how similar are HOX protein primary sequences and if differences in 
protein content mirror the differences in protein-DNA binding. For this, protein sequences were 
 
 
 
Figure 4.1 Posterior HOX protein sequence recapitulates the evolutionary homology.  
A) Schematic drawing of a HOX protein with a yellow box indicating the position of a Hexapeptide (HX) and a 
blue box indicating a position of the DNA binding domain, Homeodomain. B) Clustering and dendrogram based 
on full HOXA9-13 and HOXD9-13 protein sequences. Clustering was performed with webPRANK, European 
Bioinformatics Institute with default settings (Löytynoja and Goldman, 2010). 
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extracted from PubMed,compiled, and used as an input for the webPRANK software (Löytynoja 
and Goldman, 2010). Sequences were clustered according to protein similarity. Additionally, the 
C-terminal part of proteins, carrying the Homeodomain, was annotated for easier comparison 
(Figure 4.1A and B). Expectedly, this analysis confirmed Homeodomain is the most conserved 
part of the HOX protein. Furthermore, individual paralogy group (PG) TFs (e.g. 
PG13=HOXA13 & HOXD13 or PG11=HOXA11 & HOXD11) always clustered closest to 
each other (Garcia-Fernandez, 2005). 
The analysis also demonstrated that HOX13 TFs diverged somewhat further apart from the rest 
of the HOX-TFs, indicating that HOX13 protein ancestor probably acquired some changes 
before diverging into HOXA13 and HOXD13. Surprisingly, although HOXD12 TF is 
functionally redundant with HOXD13, it clustered closer with more anterior HOX proteins 
(here, HOX9 and HOX10) than with HOX13 indicating that protein sequence alone is not a 
suitable functional indicator. Finally, I examined protein conservation of the three Homeodomain 
(HD) helices. For this, the three alpha helices were annotated in their respective Homeodomain 
and then examined for the conservation (Figure 4.1B, in yellow). Expectedly, helix 3 was the 
most conserved amongst nine HOX-TFs, as most of the sequence recognition and the protein-
DNA contact is established through this helix. 
4.2 Characterization of chMM as a System for Functional HOX 
Investigation 
Transcription factors are nuclear proteins that bind motifs on the DNA and control the 
transcriptional output of their target genes. To investigate a transcription factor binding and, its 
regulatory and functional effects, one has to have a highly specific antibody and a sufficient 
amount of tissue available. In this study, however, to satisfy these two simple criteria it was 
necessary to design a novel approach.  
Firstly, to investigate the binding of nine posterior HOX-TFs, it was necessary to discriminate 
between the individual proteins. As demonstrated by the conservation analysis, HOX proteins 
are remarkably homologous, particularly in their DNA binding domain (Figure 4.1B). Therefore, 
there is no available antibody, commercial or homemade, that can distinguish between these nine 
HOX proteins. Furthermore, overlapping pattern expression prevented the use of a meta-
antibody. To overcome these issues, nine posterior HOX genes (HOXA9, A10, A11, A13 and 
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HOXD9, D10, D11, D12, and D13) were FLAG-tagged and cloned into an RCASBP(A) vector 
(Figure 4.2A). In this way, I introduced a unique epitope for which a highly specific antibody 
was readily available.  
Secondly, to obtain sufficient amount of the input material chicken micromass (chMM) system 
was adapted. In this system, mesenchymal stem cells (MSC) are harvested from chicken embryos 
at the HH24,  infected with the RCASBP(A) virus and cultured for up to 15 days (Figure 4.2A) 
(Morgan and Fekete, 1996). chMM system is a chondrogenic cell culture system where isolated 
MSCs are plated in a high-density droplet ensuring hypoxic conditions that resemble conditions 
 
 
Figure 4.2 Over-expression of the HOX-TFs induces specific transcriptional programs that 
shape chondrogenesis in the chMM.  
A) Alcian Blue quantification of the chMM cultures that express individual HOX-TFs, at the five time points, day 
3, 6, 9, 12 and 15 post infection. B) Alcian Blue and Eosin staining of the chMM cultures, here visualized at day 9. 
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in the developing limb bud (Morgan and Fekete, 1996). Importantly, at the HH24 stage, all of the 
investigated HOX genes are expressed at least in a subset of cells. Therefore, both, adequate 
cellular environment and HOX cofactors are present which is a prerequisite for a comprehensive 
investigation of the HOX-TF binding.  
Thirdly, RCASBP(A) is a modified chicken retrovirus where the oncogene is replaced with the 
individual gene of interest (GOI) and moderately overexpressed (see Chapter 4.3. for details).  
With these modifications, it is possible to obtain GOI with the unique epitope in a native cellular 
environment and study the binding of HOX-TFs as accurately as possible.  
In this system, I first investigated the impact of overexpressed HOX genes to the chondrogenic 
process undergoing in the chMM cultures. This was surveyed with two histological staining: 
Eosin, to examine general cell morphology; and Alcian Blue, to determine the chondrogenic 
potential. Four individual cultures were fixed and stained on day 3, 6, 9, 12 and 15 post 
RCASBP(A)-HOX3 infection. Stained cultures were, examined visually and compared to the 
control. Additionally, Alcian Blue staining was measured which allowed quantification of the 
chondrogenic potential in these cultures. Both, the appearance and quantification of the chMM 
cultures demonstrated that HOX genes can both, inhibit or accentuate the chondrogenic 
potential of the culture (Figure 4.2B and C). Interestingly, the extent of the inhibition or 
accentuation of chondrogenesis differed between the nine HOX-TFs, with no correlation to 
protein sequence conservation. However, the paralogy groups generally exhibited similar impact 
on the chondrogenesis, except PG9 (Figure 4.2B and C). More specifically, PG10 accentuates, 
whereas PG11, PG13, and HOXD12 inhibit chondrogenesis which is in line with known HOX-
TF effects on the chondrogenesis (Kuss et al., 2009; Ibrahim et al., 2013). Surprisingly, however, 
HOXA9 and HOXD9 overexpression affect the cells oppositely, one inhibiting and the other 
exacerbating the undergoing chondrogenesis (Figure 4.2B and C).  
 On the other hand, Eosin staining gives information about the morphology of central 
chondrogenic condensation and the surrounding fibroblastic-like cells. Cultures stained with 
Eosin exhibited changes at both, chondrogenic and fibroblastic-like cells. Surrounding 
fibroblastic-like cells in all, but HOXA13 culture, appear in thick rays radiating from the central 
condensation. In the HOXA13 culture, these cells appear less dense and also populate smaller 
area than in other chMM cultures. These observations are consistent with the diverse functions 
HOX genes play in chondrogenesis (Raines et al., 2015).  
                                                 
3 chMM cultures were infected individually with nine HOX constructs. 
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Taken together, these preliminary analyses demonstrated that all HOX-TFs distinctly impact 
chondrogenic potential of the chMM culture and that paralogy groups often similarly affect 
undergoing chondrogenesis. Furthermore, these results corroborated previous findings and 
clarified effects of individual HOX-TFs to the process of chondrogenesis. Finally, these results 
confirm chMM is a suitable system for the further functional analyses of the HOX. 
4.3 Estimation of Viral HOX gene Overexpression Levels 
To ensure that the chosen methodology reaches all desired standards it was necessary to examine 
the abundance of overexpressed transcripts and proteins. Before addressing these issues, first, it 
is important to understand the here used system better. RCASBP(A) is a modified retrovirus that 
integrates into the genome and soon after the viral genes (and HOX genes) get expressed. Viral 
mRNA is polycistronic and splices in three different isoforms. Out of these three, only one splice 
variant will lead to the HOX protein product, causing quite moderate overexpression.  
To compare HOX gene expression levels between the chMM system and an in vivo system, it was 
necessary to select appropriate chick embryo tissue subsection and stage. For this, posterior, 
distal chick forelimb, at the stage HH23, was dissected in two biological replicates (Figure 4.3B). 
Posterior, distal forelimb was selected as it was the subsection best representing the expression of 
nine HOX genes. Then, total RNA was extracted and processed for RNA-seq and comparison 
with the chMM overexpressions. Therefore, only one tissue was selected for the comparative 
expression analysis of nine genes. Due to complicated HOX expression patterns in the limb bud, 
this approach had its shortcomings. Namely: 1) HOXA10 expression was present throughout the 
dissection but weakly, 2) only about 20% of the cells expressed the HOXA13, and 3) HOXD9 
was expressed only in a subset of cells (Nelson et al., 1996). Additionally, HOXD11 gene was 
expressed in all dissected cells (Nelson et al., 1996). This is relevant information, as it greatly 
facilitated correct estimation of the overexpression. 
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First, chMM RNA-seq was filtered only for the viral mRNA variant that leads to the production 
of the HOX protein. This accounted for 15%-45% of the total viral mRNA (Figure 4.3C). From 
this, the chMM HOX gene RPKM values were calculated.  
At the same time, in vivo HOX gene RPKM from the posterior, distal forelimb were calculated. 
From these numbers, an overexpression level was easily inferred and ranged from 1,42 fold for 
the HOXA9 gene up to 122 fold for HOXA13 gene. Having in mind that HOXA13 gene was 
very poorly expressed in the microdissected tissue it was expected that it would show the highest 
overexpression. However, when taking into account that only approximately 20% of the cells 
expressed HOXA13; it is clear that the overexpression level is reduced significantly. Importantly, 
HOXD11 gene, which was best represented in the microdissected tissue showed merely three 
 
 
Figure 4.3 HOX  is mildly over-expression in the chMM. 
A) Schematic representation of an RCASBP(A) vector in a linear form. Three possible splice variants are indicated 
and the position of the viral and HOX genes is accurately portrayed to comprehend the splice variants. B) A 
schematic depiction of the posterior, distal part of the HH25 forelimb in the chick embryo that was dissected for 
the comparison of the transcript abundance between the HOX expressing tissue and chMM over-expressions. C) 
Quantification of the over-expression level in the chMM in comparison to the in vivo tissue of expression. Top 
panel: Splice variant quantification from the chMM RNA-seq. Approximately one third of total viral RNA leads to 
the transcript that carries HOX and will have a viable protein product. Middle panel: RPKM values for all HOX 
genes in their own overexpression and for the tissue control experiments, in replicates. Bottom panel: 
Quantification of the over-expression level for the each of the two replicates and below the average over-
expression level. D) Western Blot of the over-expression chMM cultures for each of the nine HOX. Loaded 
protein was extracted from the same number of cells and quantified by Bradford assay to ensure comparability. 
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fold overexpression. These results corroborated overexpression folds calculated in other studies 
using the same system (Ibrahim, 2014). 
Lastly, to make sure that transcriptional differences between overexpressing cells and in vivo 
embryonic tissues are a good proxy for the protein overexpression in the chMM, a Western Blot 
analysis was performed. Here, the same amount of total protein was loaded for every chMM 
overexpression and visualized on the blot using the same antibody. Importantly, chMM displayed 
a uniform expression level amongst all nine HOX proteins.  
Altogether, the overexpression fold induced by RCASBP(A)-HOX constructs are quantifiably 
mild, both on transcript and protein level. Therefore, the chMM system with this kind of 
overexpression was deemed suitable to use for subsequent HOX-TFs binding and functional 
analyses. 
4.4 Characterization of Regulatory Programs Induced by 
Individual HOX-TF Overexpression 
4.4.1 Comparative Analysis of Induced Regulatory Programs 
Overexpression of HOX genes in the chMM system offers a lot of possibilities to study the 
behavior of TFs and its’ binding, but also, to some degree, to study induced transcriptional 
effects. Although a cell culture approach is difficult to compare to an in vivo situation, this system 
offered a unique opportunity to study transcriptional programs induced by an individual HOX 
gene which is impossible in vivo due to their overlapping expression patterns and functional 
redundancy.  
General Transcriptional Analysis 
First, RNA was collected from the chMM cultures at day six post-infection. This time point was 
selected to ensure high cellular infection rate. RNA was then sequenced, mapped and 
differentially regulated genes were generated. To do so, RNA-seq from every HOX 
overexpression culture was compared with RNA-seq from an uninfected control chMM culture. 
Differentially regulated genes were filtered according to the p-value, base mean expression and 
fold change. Total of 166 and 213 genes were found to be differentially regulated for the 
overexpression of the HOXA10 and HOXA11 genes, respectively (Figure 4.4A). However, 
HOXA13 and HOXA9 overexpressions generated a much higher number of differentially 
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regulated genes than the rest of the HOX overexpressions. HOXA13 gene overexpression 
regulated a total of 601 genes and HOXA9 598 genes.  
Next, I compared induced transcriptional programs. For this, top 50 differentially regulated genes 
from every HOX induced culture were selected and clustered (Figure 4.4A). Clustering detected 
several significant findings. First, HOX genes induce similar transcriptional programs and share 
many target genes. Here, induced transcriptional programs are quite redundant since only 206 
genes were found in the top 50 differentially regulated genes among nine datasets. This result 
demonstrated that functional redundancy is present at the individual targets as well as on a gross 
anatomical level. Additionally, hierarchical clustering uncovered some associated features 
reminiscent of HOX in vivo functions. Exemplarily, HOXD13, and HOXD12 transcriptional 
programs cluster closer than the PG10, PG11, and HOXD9 which is reminiscent of their roles in 
the limb patterning, where HOXD13 and HOXD12 TFs act in autopod and HOXD9, PG10, 
and PG11 in zeugo-/stylopod,(Figure 4.4A). Second, although, HOXA13 and HOXA9 induced 
more distinct regulatory programs, their strongest regulated target genes were common target 
genes regulated by other HOX genes as well (Figure 4.4A). 
Finally, a closer examination of target genes uncovered these genes were primarily proliferation- 
and differentiation-related genes, with almost no known developmental TFs present. Then, 
differentially regulated genes were subjected to the gene ontology (GO) analysis to identify major 
processes induced by overexpressions. Expectedly, the GO analysis mainly identified terms 
related to skeletal development, vertebrae transformation, and anatomical processes, as these 
processes are known to depend on HOX genes (Figure 4.4B). 
HOX Autoregulation 
Due to the complex HOX gene expression pattern little direct evidence is available to describe 
HOX autoregulation. Therefore, I decided to examine the chMM transcriptomic data to identify 
if any HOX autoregulation is detectable. For this purpose, RPKM values were calculated for each 
of nine HOX genes in the overexpression experiments, in comparison to the control experiment 
(Figure 4.4C and D). This analysis uncovered an interesting tendency for posterior gene 
upregulation. More specifically, the overexpression of every tested HOX gene, except HOXA9, 
leads to HOXD13 and HOXA13 upregulation (Figure 4.4C and D). These findings suggest a 
trend where protein products of more anterior HOX (e.g. HOXD10) genes positively affect the 
expression of more posterior genes (e.g. HOXA13 and HOXD13).  
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Together, these findings showed that a single HOX gene overexpressions are sufficient to induce 
redundant transcriptional programs. Furthermore, no single posterior HOX gene overexpression 
can induce the change in expression of well-known developmental master regulators. In this 
view, the impact of individual HOX gene expression is relatively limited and is likely affecting 
 
 
Figure 4.4 HOX induce similar transcriptional programs.  
A) Hierarchical clustering and dendrogram for every gene in replicates. Following parameters were used: top 50 
deferentially regulated genes for every sample, base mean≥30, log2fold change≥1, pvalue≤10-5.  B) The RPKM 
values were calculated for the HOX genes in all the over-expression experiments. RPKM values are colored 
according to regulation. Most down-regulated showing in deep blue to the most up-regulated showing in bright 
red. C) A schematic representation of the HOX autoregulation based on the data in B). Color of the arrows 
represents either the up-regulation in red or down-regulation in blue. D) Gene Ontology (GO) analysis with 
GOrilla and GREAT tools from left to right, respectively (Eden et al., 2007, 2009; McLean et al., 2010). The input 
genes for these tools were same in A).  
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biological processes more extensively when expressed in combination with other paralogues. 
Lastly, HOX genes displayed a degree of autoregulation within and between the clusters, 
suggesting an even more complex situation when several HOX genes are expressed in the same 
tissue/time.  
4.4.2 Paralogy Group (PG) Specific Regulatory Programs 
HOX genes from the same paralogy group are remarkably homologous and functionally 
redundant (Zakany & Duboule 2007). Therefore, next, I investigated functional redundancy 
within individual paralogy groups. For this, every HOX induced transcriptional programs were 
directly compared to its paralogue’s (e.g. HOXA10 vs. HOXD10). This comparison uncovered 
that PG10 and PG11 target almost all of the same genes, with only 7 and 11 differentially 
regulated genes within their groups, respectively (Figure 4.5B). Conversely, the PG9 and PG13 
displayed most variability in their respective paralogy groups with 567 and 263 differentially 
regulated genes, respectively (Figure 4.5B).  These results indicate that some paralogy groups are 
more redundant than others, at least in this system. Interestingly, a comparison between 
HOXD13 and HOXD12 induced transcriptional programs identified only 30 differentially 
regulated genes, corroborating previously defined functional redundancy between these genes 
(Kmita et al. 2002; Kmita et al. 2005). 
Finally, GO analysis of the PG9 and PG13 differentially regulated genes was performed to 
determine the processes associated with these genes. While both, PG9 and PG13, impact similar 
features like the anatomy of the limb, vertebrae, and autopod; the cellular components which are 
affected by these processes differ. PG9 group of proteins is enriched for the terms like PRC1 and 
PcG complex whereas the PG13 group affects processes mainly associated with extracellular 
matrix (Figure 4.5C).  This further describes the differences within these paralogy groups and 
indicates that even apparent discrepancy in the targeted genes somehow could lead to the similar 
phenotypic consequence.  
Taken together, the paralogue-specific transcriptomic analysis showed that while there is a 
general redundancy within the HOX induced transcriptional programs, the extent of the 
redundancy is individual to paralogy groups. In such way, PG10, PG11, and to some extent the 
neighboring HOXD13-HOXD12 induce many same targets, whereas PG9 and PG13 differ 
extensively. GO analyses between the more diverse paralogy groups displayed puzzling plasticity 
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as quite distinct transcriptional programs seem to be linked with similar associated processess and 
phenotypic outcomes. 
 
 
 
 
 
Figure 4.5 PG10 and PG11 induce nearly identical regulatory programs.  
A) All up-regulated and down-regulated genes quantified for every sample. Deferentially regulated genes were 
selected using the following parameters: base mean ≥ 100, log2fold change ≥ 1, p-value ≤ 10-5. B) Paralogy group 
specific comparison of deferentially regulated genes. Parameters used as in B). C) GO analysis of the deferentially 
regulated genes from the PG9 and PG13 using GREAT (McLean et al., 2010). 
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4.5 Analysis of HOXA/D TF Binding 
DNA binding is most essential HOX property. However, it is largely understudied due to the 
technical limitations. Using chromatin immunoprecipitation followed by the next generation 
sequencing (ChIP-seq), I generated HOX genome-wide binding profiles with few hundred base 
pair resolution. This technique allows not only the localization of the protein binding but also for 
better understanding of the binding mechanism and discovery of putative cofactors. Here, I 
employed ChIP-seq to map, investigate, and compare genomic binding profiles of HOX-TFs. 
4.5.1 Initial Analysis and Validation of HOX-TF ChIP-seq 
For a successful ChIP-seq, it is imperative to have a highly specific antibody. For HOX, this was 
for a long time the most limiting factor. Here, however, this problem was circumvented with a 
design of a fusion gene that contains an N-terminal, unique epitope followed by the HOX gene 
of interest. Still, even with all the requirements met, performing a high-quality ChIP-seq is not 
trivial and one must thoroughly examine ChIP quality and reproducibility. For this, I used an 
established pipeline that was designed and implemented according to the ENCODE guidelines 
by Dr. Daniel M. Ibrahim and Mr. Peter Hansen (Li et al., 2011; Landt et al., 2012).  
Two most useful criteria for measuring the quality of ChIP-seq are high enrichment and 
reproduciblity between biological replicates. First, ChIP-seq enrichment quality is measured for 
every ChIP-seq replicate and visualized with the SPP plot (Figure 4.6A) (for details see Chapter 
3.6.3). All here performed ChIP-seq results passed the initial analysis. However, few samples (e.g. 
HOX9 and HOX10) scored somewhat lower on the enrichment analysis even after performing 
three biological replicates. For these samples, I followed ENCODE guidelines that require 
slightly marginal ChIP-seq to be checked for reproducibility and found they are highly 
reproducible despite marginal enrichment (Appendix 1). Then, as suggested by ENCODE 
guidelines, for these TFs I chose two best performing replicates and continued the downstream 
analysis (Li et al., 2011; Landt et al., 2012). 
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Second, ChIP-seq samples were performed in biological replicates which had to meet the 
reproducibility requirements (irreproducibility discovery rate, IDR)(for details see Chapter 
3.6.3). Having two highly reproducible experiments is crucial since ChIP-seq is an experiment 
with many wet-lab variables and very few checkpoints. Here, the IDR analysis for every ChIP-seq 
experiment verified the biological reproducibility of binding sites (Figure 4.6B and Appendix 1). 
Furthermore, IDR analysis also allowed for the discovery of reproducible binding sites and 
suggested the number of high-confidence, reproducible peaks (Figure 4.6B right panel) (for 
details see Chapter 3.6.3). With this pipeline, the number of reproducible peaks for HOX-TFs 
ranged between 13 236 and 29 261 for HOXA13 and HOXA10, respectively (Appendix 1). 
 
 
Figure 4.6 HOXD11 ChIP-seq dataset are reproducible.  
A) SPP cross-correlation analysis of the two HOXD11 replicates, Replicate A and Replicate B indicating the signal 
to noise ratio (NSC and RSC), fragment length estimate and strand shift. B) Irreproducibility Discovery Rate 
analysis (IDR) checking reproducibility of data between two biological replicates (Black dots - reproducible peaks, 
red dots - irreproducible peaks). The diagram on the far right depicts the number of called peaks above the selected 
threshold. All the peaks discovered under the threshold (dotted red line) are reproducible peaks (Li et al., 2011; 
Landt et al., 2012). 
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Furthermore, peaks mapping to mitochondrial DNA or the poorly assembled parts of the 
chicken genome were excluded from any subsequent downstream analysis of the ChIP-seq data.  
4.5.2 Identification of Posterior HOXA/D TFs Binding Sites 
Posterior HOXA/D are structurally very similar as demonstrated in Chapter 4.1. Despite this, 
HOX-TFs, particularly paralogy groups PG9 and PG13, demonstrated quite unique induced 
regulatory programs as described in Chapter 4.4. Findings presented in these two chapters 
demonstrate internally detected HOX paradox. To gain insights into HOX paradox in the 
following chapters I analyzed and compared HOX-TF binding profiles, their canonical, and 
noncanonical binding sites.  
First, HOX ChIP-seq data were mapped and displayed using UCSC browser to visualize binding 
and to aid the later interpretation of results (Figure 4.7A). A quick browsing of data indicated 
that much like proteins themselves, binding patterns are partially redundant (Figure 4.7A).  
However, while many genomic locations harbored binding of several HOX-TFs, binding of all 
nine HOX-TFs at the same location was a rarer event. Additionally, some genomic locations 
were bound only by one HOX-TF or only one paralogy group. To compare these binding 
profiles in an unbiased way, I collected genome-wide binding sites and performed Principal 
Component Analysis (PCA). PCA resulted in a major principal component (PC1), describing 
37% of the variance in the data, and several smaller components, most prominently principal 
component 2 (PC2) representing some 13% variation in the data. Two major principal 
components were then plotted to compare HOX binding profiles (Figure 4.7B). PCA analysis 
uncovered two major regiments. First, PG13 binding pattern are separated from other HOX-TF 
binding along the PC1, indicating there is a subset of binding sites only bound by PG13. Second, 
an unusual and novel subgrouping appeared along PC2 which did not correlate with any known 
HOX property or function (Figure 4.7B). This novel subgrouping separated HOX-TF binding 
in two groups, which were named: Group 1 (HOXA11, HOXD11, and -D13); and Group 2 
(HOXA9, -A10, -A13, HOXD9, -D10, and -D12). 
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Next, I performed a pairwise analysis between each HOX-TF, primarily to investigate the binding 
redundancy within the paralogy groups. For this, top 10 000 peaks of every dataset were crossed 
with all peaks of the second dataset since a total number of identified peaks varied between nine 
datasets (Figure 4.7C). This analysis revealed that paralogy groups are often highly redundant 
sharing, 19-29% binding sites within PG13 (HOXA13-HOXD13), 58-65% within PG9 
 
 
Figure 4.7 Posterior HOXA/D uncover novel sub-grouping according to their genome-wide 
binding profiles.  
A) UCSC tracks of the HOX ChIP-seq profiles at a random region in the chicken genome. B) Principal 
Component Analysis (PCA) of the first two components based on the HOX binding. C) Pairwise analysis of the 
HOX co-occupancy of same genomic regions. 
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(HOXA9-HOXD9), 78-81% within PG10 (HOXA10-HOXD10), and 86-85% within PG11 
(HOXA11-HOXD11) (Figure 4.7C). The observed reduction of the PG13 common binding can 
be partially attributed to a poorer reproducibility of the HOXA13 ChIP-seq replicates. However, 
a correlation between binding redundancy and transcriptional redundancy indicates that HOX 
biological properties are a more likely culprit. Specifically, PG9 and PG13 show less binding 
redundancy and less redundancy in their induced regulatory programs. In contrast, the PG10 and 
PG11 show highly redundant binding and highly redundant induced regulatory programs. While 
these observations are purely associative, they indicate that observed binding sites represent true 
binding events with functional consequences.  
This study generated the first record of vertebrate, in vivo, genome-wide binding maps of 
posterior HOXA and HOXD-TFs demonstrating that posterior HOX-TFs sometimes tend to 
bind same genomic locations. This is especially prominent within some paralogy groups (PG10 
and PG11), but less so within other paralogy groups (PG9 and PG13). Finally, binding profiles 
revealed a novel and unexpected subgrouping that could not be justified by any known functional 
or biochemical property.  
4.5.3 Functional Validation of Posterior HOXA/D TF Binding 
Transcription factors, like HOX, most often bind at distal regulatory elements. Therefore, it is a 
challenging task to functionally validate their binding. For this purpose, it is necessary to 
investigate functionality of individual binding events in detail. However, such approach is time 
consuming and would lead the analysis to a target specific approach. A genome-wide alternative 
approach is to use existing functional database and investigate binding at known limb-specific 
enhancers.  
For this purpose,  I used the VISTA enhancer browser (Visel et al., 2007). VISTA enhancer 
browser is an online resource of experimentally validated human and mouse cis-regulatory 
elements. First, human and mouse limb-positive and fore/midbrain-positive enhancers were 
selected. Limb-positive enhancers were used as a positive functional validation of HOX-TF 
binding and fore/midbrain positive enhancers were used as a negative control. Furthermore, 
fore/midbrain positive enhancers were additionally screened to exclude enhancers active in any 
HOX-expressing tissues, to prevent false positives. After successful enhancer selection, 
coordinates were lifted over from human or mouse onto the chicken genome. Since VISTA 
Enhancer Browser selects cis-regulatory elements for functional testing by conservation, it was 
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possible to lift over a majority of VISTA enhancers. A total of 160 limb-positive enhancers and 
161 of fore/midbrain-positive enhancers were successfully lifted over. Then, HOX-TF binding at 
these enhancers was tested. A total of 41% (65/160) of limb-positive enhancers was bound by 
one or more HOX-TFs, whereas only 5% (8/161) of fore/midbrain enhancers were bound 
(Figure 4.8A). More specifically, individual HOX binding was present at 27 and 51 limb-specific 
 
 
Figure 4.8 HOX bind to 41% of all mouse and human VISTA-tested limb enhancers.  
A) HOX binding to the limb-positive enhancers, and fore- and midbrain positive enhancers. The enhancers were 
lifted over from either the mouse or human genome to the chicken Galgal4 genome and then the binding was 
tested. B) Clustering of the HOX binding at limb or brain enhancers. 
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enhancers for HOXA13 and HOXA11, respectively. For comparison, HOX-TF binding at the 
fore/midbrain enhancers ranged between one and up to the four enhancers, in total. 
To investigate this in more detail, HOX binding at these enhancers was clustered (Figure 4.8B). 
Interestingly, about half of HOX-positive limb enhancers were bound by at least two different 
HOX-TFs. Therefore, there are two subsets HOX-bound limb enhancers, the commonly 
occupied enhancers, and more specific enhancers. Finally, the dendrogram representing the 
HOX-bound limb enhancers indicated the paralogy groups often occupy same enhancers 
(Figure 4.8B). Specifically, even though HOX-TFs commonly bind many of limb-positive 
enhancers, PG9, PG10, and PG13 bind most of the same enhancers (Figure 4.8B).  
These results functionally validate HOX-TF binding sites identified in this study. Furthermore, it 
also indicates there are distinct subsets of  HOX-binding limb enhancers, common and specific, 
leaving room for speculation on the possible roles of these two tiers of HOX-bound enhancers. 
4.5.4 Primary Motif Analysis 
Transcription factor binding is often best described by motifs overrepresented in ChIP-seq data. 
Binding sites can contain a diverse set of motifs, primary and secondary, which describe different 
binding modes of the investigated TF. Exemplarily, overwhelming and predominant presence of 
a motif (primary motif) belonging to the ChIP’ed protein means that most of the sites likely 
represent direct binding. Conversely, presence of slightly changed primary motif can infer the 
cofactors’ influence on the TF-DNA binding. HOX-TFs are particularly notorious for their 
dependency on the cofactors. So far, this phenomenon has been studied, with large in vitro 
screens on protein binding array (PBM) and SELEX (Berger et al. 2008; Jolma et al. 2013; 
Slattery et al. 2011; Jolma et al. 2015). Alternatively, in vivo cooperative HOX binding has been 
studied only on several loci in Drosophila (Crocker et al., 2015). However, no data exists to 
describe in vivo, genome-wide binding of HOX-TFs.  
Here adapted chMM system, allowed investigations of genome-wide HOX-DNA binding in the 
presence of the cofactors, and in an adequate cellular environment. Therefore, the first aim was 
to identify de novo motifs present in HOX ChIP-seq datasets and to infer binding modes from 
these data. 
To investigate the overrepresented binding motifs top 5 000 peak summits (151bp length each) 
were used as an input for de novo motif analysis (RSAT tool) (Figure 4.9A). Most strongly bound 
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peaks were selected since these peaks often represent direct binding. Thus, primary motifs 
describing direct binding will be most abundant. Top three overrepresented motifs were 
identified and reported, except for HOXD9 where only two overrepresented motifs were found 
(Figure 4.9A). Furthermore, HOXD9 and HOXA9 each uncovered one motif that was known 
to be a composite site of HOX and a cofactor. Interestingly, an HOXA9 non-HOX motif, 
TTCATGAA was closely matched to an HOXA9-PBX1 motif identified by crystallography 
(Figure 4.9B). This finding illustrates the importance of latent specificity for the HOX-DNA 
binding and demonstrates it is possible to identify specific in vivo motif changes using this system 
and analysis (LaRonde-LeBlanc 2003; Slattery et al. 2011).  
Up-to-date any and all available HOX-DNA binding data derives from in vitro analyses. 
Therefore, oligo motifs that bind to Homeodomain with the highest affinity represent data that 
derived from these in vitro analyses (Figure 4.9A, right panel). In comparison to these published 
data, Group 1 HOX had greater tendency to change primary motifs, especially the typical HOX, 
–TAAA 3’ part of the motif. The entire Group 1 had this –TAAA 3’ part changed to a –TGAA 
3’. Furthermore, 5’ part of the sequence was more prominent and changed from the 
N[C/T][C/A]A to G[C/T]AA (Figure 4.9A).  
Group 2 also had changed motifs but to varying degree. HOX11-TFs exhibited changes in the 
entire motifs while HOXD13 motif was minimally changed. HOX11 paralogues had a more 
versatile 5’ part of the motif which was changed from an in vitro G[T/C][C/A][G/A to an in vivo 
G[T/C][A/C]A (Figure 4.9A). Group 2 motifs also had well conserved 3’ –TAAA tail, although 
this tail was sometimes interchanged with the –TGAA (Figure 4.9A). Lastly and importantly, 
binding of the PG13 proteins demonstrated these two proteins are most commonly bound by 
their own canonical, monomer-like motifs (Figure 4.9A). Furthermore, HOXA13 and HOXD13 
have been reported, to indistinguishably bind both their own and each other’s canonical motifs 
(Taneda et al., 2004; Zhang et al., 2011; Jolma et al., 2013, 2015; Turner et al., 2014). 
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Figure 4.9 De-novo motif analysis uncovers distinct changes in binding preferences.  
A) de novo motif analysis of top 5 000 peaks using RSAT tool (Thomas-Chollier et al., 2012). B) Comparison of the 
HOXA9 second motif to the PBX1-HOXA9 composite site motif using TOMTOM tool (Gupta et al., 2007). C) 
Quantification of the HOX binding through its primary motifs (direct binding) using FIMO tool (Grant, Bailey and 
Noble, 2011).  
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Similarly, in this study, de novo motif analysis confirmed that both HOXD13 and HOXA13 bind 
their own and each other’s canonical motif CCAATAAA and CTC[G/A]TAAA, respectively 
(Figure 4.9A). Finally, I found the canonical 3’ -TAAA tail of the PG13 motifs to be more 
conserved within this group than for the rest of the HOX-TFs. 
Primary motifs demonstrated cofactors have a substantial impact of on the direct HOX-DNA 
direct binding, except for the HOX13 TFs. To understand how many sites rely on this binding 
mode, it was necessary to quantify this direct binding. Using FIMO, all of three primary de novo 
discovered motifs were quantified in their respective HOX-TF binding sites. Quantification of 
the direct binding demonstrated three main things. First, the direct HOX-DNA binding is low. 
Only 20%-58% of the top 1 000 peaks contained primary motif for HOXD9 and HOXA13, 
respectively (Figure 4.9C). This number decreases in the top 10 000 peaks to 16%-45% for 
HOXD9 and HOXA13, respectively (Figure 4.9C). In all peaks, direct binding is reduced down 
to 13%-44% for HOXD9 and HOXA13, respectively (Figure 4.9C). It is expected to see a 
decline in the number of the primary motif as the search expands to all peaks since the most 
strongly bound peaks are most often are bound directly. Second, Group 1 demonstrated less 
direct binding than Group 2. This is accompanied with Group 2 binding more often through 
canonical sites than Group 1, which is particularly the case for HOX13 paralogues. Third, 
analysis of direct binding suggested that most of HOX-DNA binding does happens 
indirectly through tethering or indirectly through some other mechanism. 
Altogether, de novo motif analysis uncovered presence of altered, noncanonical motifs for all 
HOX-TFs. Alterations in primary motifs partially explain subgrouping discovered in the PCA 
analysis, but cannot explain HOXA13 presence in the Group 1, nor what characterizes Group 2. 
Direct binding quantification further corroborated these findings and suggested direct binding as 
a partial driver of Group 1 and Group 2 discrepancy. 
4.5.5 Secondary Motif Identification 
De novo motif analysis is a useful tool to uncover which motifs are overrepresented in binding 
data. The advantage of such analysis is its unbiased nature as such approach will discover any 
over-represented motif. Since previous analyses indicated that HOX-TFs do not always bind 
directly, it was necessary to investigate which possible other TFs might be involved. First, all peak 
summits were (151bp each) subjected to RSAT motif analysis (Thomas-Chollier et al., 2012). This 
search identified the presence of several non-HOX motifs in Group 1, but not Group 2, which is 
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partly due to the fact that Group 1 HOX-TFs do not often bind DNA directly. Furthermore, no 
secondary motifs were discovered in HOXA13 binding data indicating that strong presence of 
primary motifs might be overshadowing de novo motif search for other motifs. In brief, this 
analysis uncovered four different secondary motifs: an AP1 motif; an HOXA9-PBX1 motif that 
was also discovered in the previous motif analysis; a CG-rich motif that was not matched with 
any TF; and a CTCF motif (Figure 4.9B, Figure 4.10 and Appendix 2) (Gupta et al., 2007; 
Thomas-Chollier et al., 2012; Mathelier et al., 2014).  
 
 
 
 
Figure 4.10 Expanded de novo motif analysis uncovers three major classes of secondary motifs. 
TOP: HOX data where de novo motif was discovered and e-values. MIDDLE: de novo discovered motifs. 
BOTTOM: best match motifs from database.  
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4.5.6 Quantification and Verification of AP1 and “Unmatched” as 
secondary Motifs 
HOX binding that is impoverished of direct binding is necessary to investigate as it is informative 
of other than direct TF-DNA binding. Above presented descriptive analysis of secondary motifs 
was a first step to identify potential cofactors or tethering factors. However, it is necessary to 
investigate these motifs in more detail as they can be present either at a background level 
 
 
Figure 4.11 AP1 motif is present in HOX binding data as a secondary motif but at a very low 
amount.  
A) Quantification of the AP1 motif in HOX data with FIMO tool (Grant, Bailey and Noble, 2011). B) Probability 
of finding the AP1 motif and AP1 motif positioning in HOX binding data. Analyzed with Centrimo tool (Bailey 
and MacHanick, 2012). 
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throughout the binding site or they can be enriched at the peak summit like the primary motif 
would be.  
Since true secondary motifs, unlinked to HOX4, are only AP1, “Unmatched”, and CTCF 
subsequent analysis was focused on these motifs. In order to investigate motifs enriched in each 
of the HOX peaks two software were used, Centrimo and FIMO (Grant, Bailey and Noble, 2011; 
Bailey and MacHanick, 2012). Centrimo detects localization of the motif in peak and the 
probability of finding the motif in respect to peak summit. On the other hand, FIMO allows for 
the detection and quantification of specific motifs. 
AP1 Motif Investigation 
To examine AP1 motif, an AP1 motif position weight matrix (PWM) was extracted as identified 
in the HOXA10 dataset. Then, all nine HOX-TF binding sites were investigated for the central 
enrichment of the AP1 motif. Centrimo analysis demonstrated AP1 motif was present at HOX 
peaks with varying probability in comparison to the primary motif (Figure 4.11 and Appendix 
3). Only the PG9 and PG10 had an AP1 motif present around the peak summit (Appendix 3). 
Furthermore, AP1 motif was present in all HOX data in about only 3-6% of the peaks (Figure 
4.11A). These analyses demonstrated that this TF motif is often present at varying positions and 
is not highly enriched in HOX binding data.  
“Unmatched” Motif Investigation 
Next, the “Unmatched” motif was subjected to the same analysis as the AP1 motif. First, the 
“Unmatched” motif was found with low probability around the summit of all HOX-TF binding, 
with the notable exception of the HOXA13 where this motif was found to be centrally 
positioned at the summit site and with high probability (Figure 4.12B and Appendix 4). This 
motif was slightly more abundant in Group 1 than in Group 2 (Figure 4.12A). However, the 
importance of the “Unmatched” motif was disputed with Centrimo analysis since it was not 
detected centrally at the peak summit. 
Lastly and importantly, none of the above holds true for the HOXA13 which is the only HOX-
TF where the “Unmatched” motif is present at the peak summit and quite abundantly as well 
(Figure 4.12B and Appendix 4). It is unclear whether this is a motif of another TFs or the 
HOXA13 protein is biased to these sites by some other mechanism and this motif is a secondary 
                                                 
4 HOXA9-PBX1 motif is not investigated here in more detail as it is known to be a feature of TALE driven, altered 
direct binding. 
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phenomenon. It will be interesting to see once this motif is associated with a protein how it will 
link to the HOXA13. 
 
 
 
 
 
 
Figure 4.12 “Unmatched” motif is present mainly in the HOXA13 binding data as a secondary 
motif. 
A) Quantification of the “Unmatched” motif in HOX data with FIMO tool (Grant, Bailey and Noble, 2011). B) 
Probability of finding the “Unmatched” motif and “Unmatched” motif positioning in the HOX binding data. 
Analzed with Centrimo tool (Bailey and MacHanick, 2012). 
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4.5.7 Quantitative and Qualitative Analysis of CTCF as a secondary 
Motif 
Positioning and Abundance of the CTCF Motif in HOX-TF Binding Sites 
Secondary motif analysis uncovered a de novo motif that was nearly a perfect match to the 
published CTCF motif. So far, CTCF has not been associated with HOX-TFs.  
First, HOX-TF binding sites were examined for CTCF motif position and abundance. Centrimo 
and FIMO analyses demonstrated that CTCF motif is centrally enriched and abundant in Group 
1 but not Group 2 binding sites (Figure 4.13A and B).  
Second, identified differential CTCF abundance was examined in detail. It was important to make 
sure this not a background signal observed only in weakly enriched HOX sites. To account for 
this, peaks of all nine HOX-TFs were split into three groups according to their binding strength, 
top 1 000, top 10 000 and all peaks and then investigated for CTCF motif abundance. While the 
results were expectedly5 mildly skewed towards all peaks, the overall differential distribution 
mainly stayed the same (Figure 4.13A). All peaks of Group 1 show a high abundance of the 
CTCF motif. Here, 22% of HOXA10 peaks carry a CTCF motif. This occupancy barely changes 
for the analysis of HOXA10 top 10 000 peaks. However, there is a more evident depletion of 
CTCF motif in HOXA10 strongest bound 1 000 peaks where CTCF is present at just 17% of the 
binding sites. Interestingly, the CTCF motif abundance in HOXA13 peaks does not change in 
three tested groups and is maintained at 23-24%. Conversely, Group 2 demonstrated consistently 
weak enrichment for CTCF motif in all three groups, ranging between 3-9%.  
Altogether, the investigation of the secondary motifs uncovered three non-HOX motifs as a 
possible HOX cofactors. Out of these three motifs, only CTCF was highly abundant and 
centrally enriched at HOX binding sites. Moreover, CTCF abundance exhibited differential 
pattern between Group 1 and Group 2 binding sites, partially explaining novel subgrouping 
discovered in the PCA analysis. 
 
 
                                                 
5 Since the strongest bound peaks are almost always direct peaks, they are enriched for the primary motifs. 
Therefore, the analysis of strongest peaks is skewed against secondary motifs, by design. 
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Figure 4.13 CTCF motif is more abundant in the Group 1 than in Group 2 HOX.  
A) Quantification of the CTCF motif in HOX data with FIMO tool (Grant, Bailey and Noble, 2011). B) 
Probability of finding the CTCF motif and CTCF motif positioning in the HOX binding data. Analyzed with 
Centrimo tool (Bailey and MacHanick, 2012). 
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Delineation of HOX and CTCF Motifs in HOX-TF Binding Sites 
De novo motif investigation and downstream analyses of primary and secondary motifs indicated a 
remarkable heterogeneity and complexity at HOX binding sites. Primary and secondary motifs 
can be present under same or different HOX binding sites. These two possibilities suggest 
different biological setups. Motifs present under the same binding site infer a possible co-binding 
and motifs present under different sites indicate likelihood of HOX being tethered to the DNA.  
Therefore, it was important to understand the relationship between HOX and CTCF motifs at 
HOX binding sites.  
 
 
Figure 4.14 CTCF and HOX motifs are not found under the same HOX binding sites.  
A) On the right: primary and secondary de novo motifs quantified and sorted according to presence of other motifs 
under the same binding site for the HOXA10 dataset. On the left: the motifs represented as discovered by the de 
novo motif analysis for HOXA10 and as published for CTCF (Jolma et al., 2013). B) Primary and secondary de novo 
motifs quantified and sorted according to the presence of other motifs under the same binding site. Analysis was 
performed for all HOX top 1 000, top 10 000 and all bound peaks with FIMO (Grant, Bailey and Noble, 2011). 
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To approach this issue, using FIMO, I delineated HOX binding sites that contain only a CTCF, 
only a HOX primary motif, or both under the same peak. The presence of the both motifs 
underlying the same binding site is unexpected since HOXA10 and CTCF motifs are quite 
different (Figure 4.14A). Such situation would hint towards a cofactor-like relationship where the 
two TFs either, bind the DNA together or perhaps interact on a protein-protein level. Here, I 
again, subdivided all nine HOX binding profiles into the strongest 1 000, 10 000 and all peaks to 
make sure that observed effect is not a background effect. Then, I identified peaks carrying 
primary HOX motifs, CTCF motif, and checked if any of the peaks contained both motifs. This 
analysis showed that primary HOX motifs and the CTCF motif are most often present under 
different binding sites, regardless of peak enrichment. In most cases, under a single HOX peak 
there is either a HOX motif or a CTCF motif present, rarely both, except for HOXA13 TFBS 
where a significant fraction of the peaks carried both motifs (Figure 4.14A and B).  
These results indicated that CTCF is a putative HOX co-factor and that it is likely helping to 
tether HOX to the DNA when there is no HOX motif. 
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4.6 Analysis of HOX Binding at Functional Chromatin 
Functional Chromatin in HOX  non-expressing Cells 
To better understand the functionality TF binding sites it is helpful to identify at which functional 
chromatin marks the binding occurs. Unfortunately, not much chromatin modification data are 
available for chicken. Therefore, it was convenient that another study was conducted, 
concomitant with this one, in the same chMM system. This parallel study investigated  
 
 
Figure 4.15 Group 1 HOX-TFs bind more often to H3K4me pre-marked regions. 
A) seqMINER analysis of HOX binding sites at the marked functional chromatin. Active promoters (H3K4me3 
and H3K27Ac); active enhancers (H3K27Ac and H3K4me1); poised enhancers (H3K4me1); repressed regions 
(H3K27me3); and bivalent regions (H3K4me3 and H3K27me3). B) HOX-TF binding at annotated genomic 
regions. 
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developmentally important chromatin marks at the day five of the chMM, uninfected cultures. 
These experiments were performed by Dr. Mickael Orgeur and published in the scope of his 
thesis and his manuscript in preparation (Orgeur, 2016). In this study, these data were used in 
order to differentially investigate position of HOX binding sites in respect to the functional 
chromatin.  
Histone modifications were mapped for both, functionally active (H3K4me1, H3K4me3, and 
H3K27Ac), and repressive chromatin (H3K27me3). Then, I used seqMINER to investigate 
functional chromatin marks in a 10kb radius of the HOX-TF binding (Ye et al., 2011). This 
analysis uncovered few general and Group-specific features of HOX-TF binding in respect to the 
functional chromatin. First, all HOX partially bind the regions enriched in functionally active 
chromatin related to enhancers (H3K4me1 and H3K27Ac), but not in functionally repressive 
chromatin (H3K27me3) (Figure 4.15A, Figure 4.16A and B-for the heatmap of H3K4me3 and 
H3K27me3 data, Appendix 8- for the heatmap of H3K27Ac and H3K4me1 data). Second, all 
HOX bind in a local minimum of the histone modification that is surrounded by the two local 
maxima on either side.6 Active chromatin, promoter specific mark (H3K4me3) is differentially 
enriched between Group 1 and Group 2. More specifically, chromatin modifications marking 
poised/active (H3K4me1) and active (H3K27Ac) enhancers were present in all datasets while the 
mark characterizing active promoters (H3K4me3) was present only in vicinity of Group 1 and 
HOXA11 binding sites (Figure 4.15A).  
Next, genomic positions of HOX peaks were examined to investigate genomic annotations of all 
peaks regardless of their functional chromatin status. Peaks could be located either in 1) 
promoters (-5 kb to +2 kb around the TSS), 2) exons, 3) introns, or 4) intergenic space (the rest 
of the genome). While most peaks mapped at intergenic regions, in total it was less than expected 
(Figure 4.15B). While the 65% of the genome is annotated as intergenic space between 52% 
(HOXA13) and 60% (HOXD13) of the peaks were found in these regions (Figure 4.15B). There 
was a slight increase in peaks located at annotated promoters. Here HOXD11/13 peaks mapped 
to 9% and HOXA13 to 21% at promoter regions, as compared to the 7% of the genome 
belonging to annotated promoters (Figure 4.15B). This finding recapitulated the tendency of 
Group1 to bind more often at the active promoters (H3K4me3) than the Group 2. Conversely, 
exon regions harboured only 2-2.5% of HOX peaks (Figure 4.15B). Lastly, together with the 
peaks in promoters, the biggest difference occurred with HOX binding at intronic regions. 
                                                 
6 This binding pattern is expected as TFBS are centered at the nucleosome free region. Naturally, such nuclesome 
free regions are devoid of histones and histone marks. 
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Genome partition uncovered that with this custom annotation 26% of the genome belongs to the 
introns. However, HOX-TF peaks mapped to 17% (HOXA13) and up to 36% (HOXD13) at the 
intronic regions, deviating apart from the expected range (Figure 4.15B). 
Functional Chromatin Changes in HOX Expressing Cells 
Investigation of HOX binding to the genome previously marked with either active or repressive 
mark shed light onto the functionality of these binding events. Furthermore, these results pointed 
out the differential preference of two groups with respect to the functional chromatin. These 
findings were used as a start point in the subsequent analysis where I monitored functional 
chromatin changes upon HOX overexpression. For this purpose, chMM cultures overexpressing 
HOXA10 and HOXD13 were used as representatives for the Group 1 and Group 2. ChIP-seq 
was performed as reported in Chapter 3.6. This time, however, two selected histone 
modifications were examined in these HOX overexpressing cultures, H3K4me3, and 
H3K27me3. H3K4me3 was selected due to the differential coverage between Group 1 and 
Group 2. Furthermore, H3K4me3 and H3K27me3 have a delicate balance over the HoxD 
cluster, and it has been shown that presence of HOX13 proteins can influence this balance 
(Beccari et al., 2016; Sheth et al., 2016). Furthermore, spreading of both marks is reportedly 
blocked by CTCF binding (Cuddapah et al., 2009; Varun Narendra et al., 2015). Therefore, I set 
out to examine changes in these two marks in overexpressions and control conditions. 
To be able to examine functional chromatin changes over the CTCF sites, a CTCF ChIP-seq was 
performed. The analysis of the CTCF reproducibility and peak calling was performed as for all 
other HOX ChIP-seq (Appendix 5). Data were clustered with seqMINER using same 
parameters around HOXA10, HOXD13 or CTCF peaks (Figure 4.16A, B, and C). First, 
analysis was focused on the changes in chromatin marks centered at HOXA10 and HOXD13 
peaks in their respective chMM cultures. Generally, coverage was higher and signal stronger in 
the data from the control ChIP-seq, making the control data always looks a bit noisier and with 
somewhat more pronounced signal. Overall, there is little change in the H3K4me3 and 
H3K27me3 mark distributions around HOXA10 and HOXD13 peaks in the control or 
HOXA10/HOXD13 cultures (Figure 4.16A and B). Furthermore, two histone marks (H3K4me 
and H3K27me) were largely devoid of signal around the HOXA10, HOXD13, and CTCF 
binding sites, especially in HOXD13 overexpression (Figure 4.16A, B, and C). This indicates 
that HOXD13 doesn’t often bind to the pre-marked chromatin, at least with respect to these two 
marks. Apparent gain of H3K4me3 mark in the Cluster 2 and 3 indicates that a subset of 
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promoters in the HOXA10 overexpressing culture get activated. However, since the signal is 
stronger in the control culture7, it is difficult to establish to which extent. Due to this, cluster 2 
and cluster 3 were not the focus of subsequent analysis.  
Next, I examined the change of H3K4me3 and H3K27me3 marks centered at the CTCF peaks 
that were identified from a CTCF ChIP-seq performed in the same system. This analysis, 
expectedly, showed that higher H3K4me3 signal at the CTCF sites in these data, as CTCF is 
known to bind at promoter regions (Figure 4.16C). More interestingly, it also showed there is an 
increase of the H3K27me3 mark over the subset of CTCF binding sites, both, in HOXA10 and 
HOXD13 overexpressing cultures (Figure 4.16C). These sites were then extracted and checked 
for their genomic position. Surprisingly, there was a gain of H3K4me3 mark at many promoters 
in cluster 4 (Figure 4.16D). In this cluster, 41% of CTCF binding sites mapped at promoters in 
comparison to 22% all CTCF binding sites. Furthermore, these binding sites were mostly devoid 
of any intronic binding. Since these binding sites located at many promoters I investigated GO 
terms association with these promoters as they are likely to direct targets of this gain of 
methylation. Interestingly, these promoters were enriched for GO terms associated with 
metabolic processes, specifically with RNA and DNA processing, cofactors, histone binding, and 
methylated residue binding. 
 
                                                 
7 The signal was also monitored on an enrichment graph in seqMINER. While the signal was weaker in the 
HOXA10 chMM it was still present.  
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Figure 4.16 HOXA10 and HOXD13 expressing cultures promote a gain in H3K27me3 at a 
subset of CTCF binding sites.  
A) seqMINER analysis of the H3K4me3 and H3K27me3 mark in the uninfected chMM culture and in the 
HOXA10 infected culture. The histone marks are centered at 5kb window around the HOXA10 binding sites B) 
seqMINER analysis of the H3K4me3 and H3K27me3 mark in the uninfected chMM culture and in the HOXD13 
infected culture. The histone marks are centered at 5kb window around the HOXD13 binding sites. C) seqMINER 
analysis of the H3K4me3 and H3K27me3 mark in the uninfected chMM culture, HOXA10, and HOXD13 
infected culture. The histone marks are centered at 5kb window around the CTCF binding sites. D) Genomic 
annotation the subset of CTCF peaks from the Cluster 4 in C). E) GO analysis of the promoters found as 
annotated in the Cluster 4. 
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4.7 Analysis of CTCF, RAD21 and HOX Co-binding  
Co-binding Quantification  
To corroborate previous results, it was essential to comprehensively and thoroughly investigate a 
possibility of CTCF-HOX co-binding. Earlier analyses detected and described CTCF motif at the 
HOX binding sites. However, so far these sites represent only putative co-binding, pending 
validation. To address this question, used CTCF ChIP-seq from same chMM setup, and then I 
investigated the binding of CTCF and its relation to HOX binding.  
First, 22 357 CTCF binding sites were reproducibly identified (Figure 4.17A). Then, HOX peaks 
 
 
Figure 4.17 HOX Group 1 bind to a proportion of same genomic locations like CTCF and 
RAD21.  
A) UCSC snapshot of the HOXA10, CTCF, RAD21 and HOXD13 binding in the Galga4 genome. B) Proportion 
of the binding sites that are occupying the same genomic locations in HOX and CTCF binding profiles for the top 
1 000, top 10 000 and all bound peaks. C) Proportion of the binding sites that are occupying the same genomic 
locations in HOX and RAD21 binding profiles for the top 1 000, top 10 000 and all bound peaks 
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were once again subdivided into strongest bound 1 000, 10 000 and all peaks and overlap 
between HOX peaks and CTCF peaks was investigated (Figure 4.17B). This analysis once again 
recreated, above defined, discrepancy between Group 1 and Group 2. Group 1 but not Group 2, 
frequently co-occupied same sites like CTCF. Co-binding in Group 1-CTCF ranged from 13% 
for HOXA/D9 to 27% for HOXA13 in the strongest bound 1 000 peaks. This changed to 15% 
and 24% for HOXD9 and HOXA10 in all bound peaks, respectively. Interestingly, just like in the 
examination of putative CTCF binding sites in HOX binding data, HOXA13 exhibits highest 
binding co-localization with CTCF in the most strongly bound 1 000 peaks. Furthermore, 
HOXA10 and HOXD10 co-bind same regions like CTCF equally abundant, regardless of peak 
strength (Figure 4.17B). Conversely, Group 2 rarely binds the same regions like CTCF. Co-
binding ranges from 2% for HOXD11 and 5% for HOXD13 for the strongest bound 1 000 
peaks. In all peaks, this changes to 3% and 8% for HOXD13 and HOXA11, respectively. These 
results corroborate earlier defined discrepancy between Group 1 and Group 2 in respect to co-
binding with CTCF.  
Second, to assess if HOX and CTCF co-bound sites are also occupied by Cohesin complex, I 
performed RAD21 (Cohesin subunit) ChIP-seq. Here, Cohesin was of particular interest as it is 
known to direct chromatin looping when co-bound with CTCF (Nora et al., 2016; Schwarzer et 
al., 2016). Upon initial quality analysis, 17 585 reproducible peaks were detected for RAD21 in 
chMM. All initial quality and reproducibility analysis were performed as for the rest of the TF 
ChIP-seq used here (Appendix 6). Then, HOX and RAD21 co-binding was investigated as 
previously for the CTCF. Overall, same pattern of discrepancy between Group 1 and Group 2 
was uncovered; where Group 1 and Cohesin appear to bind same regions more often than 
Group 2 and Cohesin. This is also in line with above-discussed CTCF-HOX co-binding 
observation. In the strongest 1 000 peaks, Group 1 HOX share between 4% and 19% binding 
sites with Cohesin for HOXD9 and HOXA10, respectively (Figure 4.17C). In all peaks, the co-
binding changes to 12% and 20% for HOXD9 and HOXA10, respectively (Figure 4.17C). 
Conversely, Group 2 HOX co-bind with Cohesin quite rarely. In the strongest bound peaks at 
best only 3% of HOXD13 co-binds with Cohesin. When compared to co-binding in all peaks, 
this changes to the maximum 7% co-binding for HOXA11 and Cohesin, indicating that reduced 
co-binding is a general feature of Group 2 regardless of peak strength (Figure 4.17C).  
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Characterization of Co-bound Sites by Motifs and Genomic Annotation 
As HOX-CTCF and HOX-Cohesin co-binding display similar pattern of discrepancy between 
Group 1 and Group 2, I hypothesized that the origin of this similar pattern are triple bound 
HOX-CTCF-Cohesin sites. To approach this issue, first, I studied the overlap of all CTCF and 
RAD21 binding sites. In accordance with other studies8, I found that 52% of all CTCF peaks 
were also bound by RAD21, and 66% of the all RAD21 peaks were also bound by the CTCF 
(Andrey et al., 2017). Next, triple HOX-CTCF-Cohesin occupied peaks were examined. Here, 
Group 1 exhibited remarkably frequent triple binding. In fact, HOX-CTCF sites were more 
frequently co-occupied by Cohesin than all genome-wide CTCF binding sites (Figure 4.18A and 
Appendix 7). Same trend was present in the Group 2 data but to a lesser degree (Figure 4.18A 
and Appendix 7). 
To identify the binding mode of co-bound bound sites, I quantified HOX primary and CTCF 
motifs in co-bound peaks. This analysis showed a remarkable shift from primary HOX motifs 
                                                 
8 These ChIP-seq were performed in Mus musculus. 
 
 
Figure 4.18 HOX-CTCF bound genomic sites often contain the CTCF motif but not HOX 
motif.  
A) HOX-CTCF bound genomic sites investigated for the presence of the binding of the RAD21. B) Quantification 
of the CTCF and primary HOX motifs in the CTCF-HOX bound genomic sites by FIMO tool (Grant, Bailey and 
Noble, 2011). C) Annotation of the genomic locations of the HOXA10, CTCF and HOXA10-CTCF binding sites. 
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towards CTCF motif (Figure 4.18B). HOX-CTCF sites largely depend on CTCF motif as a 
DNA binding mode as this motif is present in up to 73% of the co-bound sites. In comparison, 
only 62% of the all CTCF peaks carry a CTCF motif (Figure 4.18B). Furthermore, HOX-CTCF 
co-bound sites showed a mild discrepancy between the Group 1 and 2 in the content of the 
binding sites. Here again, Group 2 contains more primary HOX and CTCF motifs underlying the 
same binding sites, than it is the case for the Group 1 (Figure 4.18A). 
Lastly, genomic annotations of the co-bound peaks were examined to determine whether a subset 
of co-bound peaks have a preference for a certain genomic location and/or function (e.g. 
promoter regions). In comparison to the genomic locations of the entire HOX binding sites, 
there is aminor increase in the intergenic regions (Figure 4.18C and Appendix 9). Overall very 
little change is present in the genomic annotation of co-bound peaks in comparison to total 
HOX peaks. Therefore, CTCF-HOX co-occupancy is not preferentially occurring in any 
genomic location here examined indicating that majority of binding happens outside promoters, 
likely at cis-regulatory elements or at regions important for local genome architecture. 
4.7.1 Demonstration and Delineation of HOX-CTCF Protein-protein 
Interaction 
Genomic locations co-occupied by CTCF and HOX mostly rely on CTCF-DNA interactions. 
However, the evidence of how they could co-bind these regions is still very circumstantial. 
Therefore, I set out to demonstrate protein-protein interaction between HOX and CTCF. For 
this purpose, Proximity Ligation Assay (PLA) was employed. PLA is an essay that gives a distinct, 
dotted signal under the microscope when two proteins are in extreme proximity (i.e. when they 
are in a complex) (Figure 4.19A). Furthermore, PLA is an in situ and quantifiable assay. These 
properties allow additional insights into the abundance of HOX-CTCF interaction in individual 
nuclei since co-binding occurs in, both, Group 1 and Group 2 but to a different degree.  
To investigate the potential of Group 1 and Group 2 to co-bind with CTCF, PLA assay was 
performed with three protein combinations: 1) HOXA10-CTCF, 2) HOXD13-CTCF, and 3) 
RAD21-CTCF (see Chapter 3.5). HOXA10 was a representative for the Group 1, HOXD13 for 
Group 2 and RAD21 a positive control. As negative control, cells not expressing HOX proteins 
were used. Signal was present in the nuclei of positive control, HOXA10, and HOXD13 
expressing cells, but not in the negative control. Closer inspection of the cell nuclei, in 
accordance with the ChIP-seq results, uncovered that signal in the between CTCF and HOXD13 
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was weaker than in the positive control or CTCF-HOXA10 sample (Figure 4.19B). 
Furthermore, upon signal quantification, it became evident that there is significantly less signal in 
HOXD13 than in the HOXA10 sample (Figure 4.19C).  
Finally, to decipher how HOXA0 and CTCF interact I set out to determine which part of the 
HOXA10 protein is responsible for the contact with CTCF. If the responsible domain was 
anything other than Homeodomain, it would be possible to investigate HOX binding in the 
absence of a CTCF interacting domain and help directly determine the causality of HOX-CTCF 
co-binding. For this purpose, seven HOXA10 deletion constructs were designed and cloned in 
frame with FLAG-tag into the RCASBP(A) vector. Deletion constructs were named HOXA10-
 
 
Figure 4.19 HOXA10 and HOXD13 interact with the CTCF.  
A) A schematic overview of the Proximity Ligation Assay (PLA). B) PLA visualized under the confocal microscope 
for the HOXA10-CTCF, HOXD13-CTCF, CTCF-RAD21 (positive control) and CTCF negative control) signal. 
C) Quantification of the PLA signal detected in B). The assay was repeated in three different biological replicate. 
Student's T-test was employed to quantify the significance of the contact frequency between HOXA10 and 
HOXD13 (Student's T pval˂0.005). 
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Δ1-HOXA10-Δ7. First five deletion constructs cover HOXA10 protein in sequential deletions, 
and the last two were based on predictions of the possible protein interaction sites (Figure 
4.20A). Deletion constructs were first tested to make sure that they are localized in the nuclei. 
Naturally, at least one construct was expected to not have nuclear localization as the nuclear 
localization signal (NLS) is supposed to be deleted. These experiments showed that HOXA10-Δ5 
is largely absent from the nuclei, indicating that the NLS is located in the C-terminal part of the 
HOXA10. Next, I performed the co-IP and PLA to test HOXA10 deletion constructs and CTCF 
for protein-protein interactions. Co-IP results from the nuclear lysate were reproducible and 
demonstrated loss of contact between CTCF and HOXA10-Δ5 (Figure 4.20B). Importantly, the 
HOXA10-Δ5 carries Homeodomain and the NLS signal. Therefore it was impossible to know 
for sure if this part of the HOXA10 protein is responsible for the contact with the CTCF. 
PLA results, however, yielded a more complex picture of HOXA10-CTCF interaction. Indeed, 
the most extreme loss of signal appeared when testing CTCF and HOXA10-Δ5 interaction 
(Figure 4.20C). Since PLA is a quantitative assay, I was able to measure and compare the 
potential of other deletion constructs to interact with CTCF as well. Deletion constructs Δ2, Δ3, 
Δ6, and Δ7 all displayed a mild reduction in the contact frequency in comparison to the full-
length HOXA10 protein. This observation can be explained in at least two plausible ways. First, 
the construct deletions could destabilize HOXA10 protein causing reduced contact frequency. 
Second, identified HOXA10-CTCF interaction is not a direct interaction but rather a part of the 
larger complex. In the complex, deletions of different HOXA10 protein parts could impact the 
complex stability and cause the observed reduction in contact frequency. 
Altogether, these experiments demonstrated that HOXA10 and CTCF interact on a protein level. 
However, it was impossible to unambiguously define the region of the HOXA10 protein 
responsible for the interaction with CTCF and whether HOXA10 and CTCF directly interact or 
are a part of a bigger complex where several HOXA10 domains establish and/or maintain the 
protein-protein interactions.  
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Figure 4.20 HOXA10 likely contacts CTCF indirectly.  
A) Schematic representation of the HOXA10 deletion constructs. B) A co-immunoprecipitation (co-IP) assay 
performed with the HOXA10 deletion constructs and the CTCF. C) Visualized PLA assay with the HOXA10 
deletion constructs HOXA10 wt-CTCF, HOXA10 Δ5-CTCF, CTCF-RAD21 (positive control) and CTCF only 
(negative control). D) Quantification of the signal for all the HOXA10 Δ-CTCF pairs, in exemplary showed in C). 
This experiment was performed only once with multiple sections counted and averaged the contact per nuclei. 
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5  Discussion 
5.1 Functional Redundancy in the Induced Regulatory Programs 
5.1.1 Redundancy beyond Paralogy Groups 
Hierarchical clustering of the strongest differentially regulated genes in the chMM uncovered an 
unusual pattern. Firstly, the HOXA13 induced regulatory program clustered far from all other 
tested HOX induced regulatory programs, including its paralogue HOXD13. This is somehow in 
contradiction with the functional redundancy found during digit morphogenesis (Fromental-
Ramain, Warot, Messadecq, et al., 1996). However, it is likely that only a subset of downstream 
target genes are necessary to conduct the HOX13-induced digit morphogenesis and that they are 
out shadowed by a large number of differentially regulated genes. Secondly, HOXD12 and 
HOXD13 induce highly similar regulatory programs, separated from the ones of HOXD9 and 
HOX10/11. This finding is in line with the loss-of-function and deletion experiments in mice. 
There, a loss-of-function mutation in the Hoxd13 gene causes severe polydactyly and delay in 
ossification (Kmita et al., 2002; M Kmita et al., 2005). However, the deletion of the Hoxd13 has a 
significantly different functional outcome. Upon Hoxd13 deletion, Hoxd12 moves to the Hoxd13 
genomic position with respect to digit regulatory regions. The change in genomic position causes 
Hoxd12 to adopt a Hoxd13 wild-type expression domain. This regulatory compensation is further 
complemented by a functional compensation, as these mice are not affected by polydactyly like 
the Hoxd13 loss-of-function mice. The functional compensation is a direct evidence of 
redundancy between Hoxd13 and Hoxd12. This genetic data is further validated by the close 
clustering of HOXD12 and HOXD13 regulatory programs described in this study. 
Interestingly, a similar experiment was conducted to investigate the regulatory and functional 
compensation between Hoxd11 and Hoxd13. There, Hoxd13 and Hoxd12 deletion caused Hoxd11 
to take over the genomic position of the last Hox gene in the cluster. Like in the example before, 
this change triggers Hoxd11 to overtake Hoxd13 expression pattern. However, this mutant cannot 
rescue the Hoxd13 loss-of-function phenotype as Hoxd12 can. Therefore, not all neighboring 
genes are equally functionally redundant and interchangeable (Kmita et al., 2002; Marie Kmita et 
al., 2005; J Zakany and Duboule, 2007). These findings go well in line with clustering of induced 
regulatory programs, where indeed transcriptional programs of HOXD12 and HOXD13 
resemble more than the HOX10/11 and HOXD9.  
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5.1.2 Impact of Evolutionary Adaptation on Differentially Induced 
Regulatory Programs 
HOX-induced regulatory programs are in general very similar, especially for above-discussed 
groups. However, PG9 and PG13 paralogy groups induce highly specific regulatory programs. 
This is in sharp contrast with other paralogy groups, such as PG10 or PG11, which are strikingly 
redundant. I hypothesize that this is the result of a higher gene specialization for PG9 and PG13 
groups during evolution. This is linked to the fact that both paralogy groups, in contrast to 
others, still retain all four copies of ancestral genes. This copy number effect might have reduced 
the evolutionary pressure on each copy and allowed for gene neofunctionalization (Gehring, 
Kloter and Suga, 2009). Therefore, PG9 and PG13 genes had more opportunity to diverge 
throughout the time, which caused some paralogues to obtain new functions while others 
retained the old ones.  
5.1.3 HOX Autoregulation 
Since HOX-TFs induce similar regulatory programs in the chMM, it was imperative to 
understand if there is any HOX autoregulation present in these cultures. So far, there is little 
direct evidence for autoregulation in trans and in particular between different clusters.  
In this dataset, HOX autoregulation was detected in all nine HOX induced programs, both 
within the same cluster and between the clusters. Interestingly, the pattern of autoregulation 
appears to have a posterior bias for all HOX proteins, except for HOXA9. Specifically, 
overexpression of HOX9-12 TFs induces upregulation of HOXA13 and HOXD13 genes. This 
posterior bias is a fascinating pattern of autoregulation that is somewhat reminiscent of the 
posterior prevalence model of HOX regulation (Duboule, 1994; Duboule and Morata, 1994), in 
which the most posterior HOX expressed in tissue always determines the tissue identity. 
Furthermore, this pattern of HOXA13 and HOXD13 upregulation is comparable to the 
sequential opening and progressive transcriptional activation of the HoxD cluster. There, 
progressive cluster opening upregulates genes sequentially which helps upregulate the expression 
of their posterior neighbor until it reaches the HOX13 paralogues. Upon expression of HOX13 
paralogues, a switch from proximal to distal patterning occurs and expression terminates (Beccari 
et al., 2016). This switch is essential for the proper patterning of the distal limb. 
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Altogether, the data indicates that there could be an additional intrinsic HOX mechanism to 
activate most posterior genes, ensure proper development and termination of HOX expression. 
5.1.4 Developmental Context of Transcriptional Redundancy  
Above discussed novelties need to be put in a proper developmental context to be fully and 
correctly understood. In vertebrates, budding of the mesenchymal limb is influenced by different 
morphogen concentrations and signaling pathways building the “ground plan”. When any group 
of Hox genes are expressed in cells with the same “ground plan”, they likely impact their targets 
in a paralogue specific manner. However, if Hox genes are expressed under a different “ground 
plan”, it is likely that the target gene is a unique target (Mann, Lelli and Joshi, 2009; Wolpert, 
Tickle and Martinez, 2015). This might seem at odds with the finding that HOX proteins induce 
many similar regulatory pathways in chMM. However, this merely means that they possess a 
potential to induce these programs in an in vivo situation. Moreover, Hox genes are systematically 
expressed in a combinatorial fashion in vivo, which might trigger particular transcriptional 
outcomes that could not be quantified in the present study. So far, it is unclear how the 
regulatory regions bound by HOX-TFs function and if they need the activity of signaling 
pathways to be potentiated/activated in order to conduct their transcriptional effect properly. 
The “ground plan” that is slightly different from one part of the limb to another can, thus, 
potentially drive HOX-TFs to affect their targets differently, depending on the positional identity.  
During vertebrate limb bud development, three main signaling centers are delivering signaling 
molecules of WNT, FGF, SHH, and RA (Wolpert, Tickle and Martinez, 2015). Together, these 
signaling pathways determine positional identity of cells in the developing limb bud. chMM, 
however, does not have any signaling molecules present. Therefore, the transcriptional readout of 
the chMM-induced programs might not represent accurately the in vivo HOX target gene 
specificities. Finally, while the chMM system allows one to study the binding quite accurately, it is 
not trivial to interpret the transcriptional readout in the in vivo context. 
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5.2 Understanding Discrepancy between HOX Binding and 
Target Regulation 
5.2.1 Reproducible Low-affinity HOX Binding Sites 
ChIP-seq is a technique that enables mapping of the protein-DNA interactions. Therefore, due 
to the nature of these interactions, accurate representation of binding profiles primarily depends 
on antibody quality, abundance and stability of the protein. Here, HOX-TF ChIP-seq data have 
been generated in identical conditions, from the same pool of cells, and using the same antibody. 
Nevertheless, HOX binding profiles displayed constant and reproducible differences in the 
enrichment. More specifically, the more centrally positioned HOX, PG9, and PG10, had more 
peaks of lower enrichment than other HOX proteins. Importantly, PG9 and PG10 binding 
profiles were reproducible in at least three independent biological replicates. Thus, low 
enrichment could not be attributed to technical issues, but rather to biological properties of 
HOX-TFs. 
HOX-TFs are notorious for their dependency on cofactors, most notably TALE proteins. 
Multiple studies in the past two decades have been investigating the ability of TALE proteins to 
influence direct HOX-DNA binding (Mann, Lelli and Joshi, 2009; Crocker et al., 2015; Merabet 
and Lohmann, 2015; Merabet and Mann, 2016). Specifically, Crocker et al. (2015) showed that 
HOX-TFs co-bind with TALE proteins to low affinity bona fide HOX sites to ensure proper 
target regulation. There, Ultrabithorax (Ubx) binds with Extradenticle (Exd) to low-affinity 
binding sites at the shavenbaby enhancer. Additionally, multiple low-affinity sites are needed to 
establish robust expression of shavenbaby. This is in agreement with Farley et al. (2015), where 
they found a cluster of sub-optimal (low affinity) transcription factor binding sites are required 
for proper expression of a developmental gene. Importantly, if only high-affinity binding sites are 
present, the target gene is grossly miss- and overexpressed. Therefore, low-affinity binding sites, 
not only allow binding of developmental TFs but, are essential for the proper gene expression 
and embryonic development of an organism. 
Indeed, while binding of PG13 groups showed more direct and monomer-like binding, more 
centrally positioned PG9 and PG10 did not. Specifically, de novo motif discovery from PG13 
uncovered primary motifs that are almost unchanged from Homeodomain-DNA binding motifs 
described in vitro. However, other HOX proteins exhibited considerably changed motifs in 
comparison to their in vitro counterparts (M F Berger et al., 2008; Jolma et al., 2013). These 
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findings resemble HOX-TALE co-binding, which targets low-affinity sites with changed motifs. 
Furthermore, anterior and central HOX-TFs are known to depend more on co-binding with 
TALE proteins than very posterior HOX-TFs (Mann, Lelli and Joshi, 2009). Together, these 
findings suggest the very posterior HOX-TFs depend more on direct, perhaps monomer binding, 
than more central PGs. It is possible that this is driven by the divergence in PG13 protein 
sequences along with the maintenance of complete four paralogs (see Chapter 5.2.3). Finally, 
these findings also indicate that PG9 and PG10 low-enrichment sites are likely a HOX-cofactor 
bound low-affinity sites, or perhaps sites where HOX proteins are tethered by other proteins. 
Both possibilities determine these sites a biologically valuable contribution to the study of HOX 
binding.  
5.2.2 Common HOX binding sites 
Posterior HOX-TFs bind many same genomic locations throughout the genome. Specifically, up 
to 86% (for PG11) of the binding sites are shared within paralogy groups and up to 71% (for 
HOXA9-HOXD10) between different paralogy groups. Evidently, HOX proteins exhibit a 
remarkable binding redundancy. However, the binding redundancy does not directly translate to 
identical target gene response. In Drosophila, Distalless (dll) gene drives leg development in the 
thoracic segment and is bound by Ubx, AbdA, AbdB, Scr, and Antp. On the other hand, in the 
abdominal segment, dll is repressed by the Ubx, AbdA, and AbdB preventing leg development. 
Therefore, it is clear that the dll is a bona fide target of many HOX-TFs. Depending on the 
segment identity and presence of cofactors (co-repressors, co-regulators) and/or signaling 
molecules, bound target response will be modulated, either repressed or activated (see Chapter 
5.2.3). Thus, HOX binding doesn’t always need to be specific, as there is an additional layer of 
specificity achieved by tissue identity, cofactors, and signaling molecules (Mann, Lelli and Joshi, 
2009; Merabet and Mann, 2016). Furthermore, it is necessary to keep in mind that in vivo HOX 
genes always come in combinations, which further complicates the relationship between binding 
and target regulation. This relationship can be either collaborative (Hox code theory) or more 
antagonistic (Posterior prevalence theory) (Kessel and Gruss, 1990; Duboule and Morata, 1994). 
Since evidence from literature and this study don’t exclude either of these theories, it is likely that 
potential collaboration or antagonism is too, governed by the timing and tissue identity. 
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5.2.3 Direct HOX-DNA Binding Specificity 
TFs usually rely on the direct binding. However, additional cofactors can enhance and/or change 
the binding specificity by either tweaking the direct binding specificity or by driving the indirect 
binding (Slattery et al., 2014). HOX proteins are known for their discrepancy between their 
binding and target regulation specificity, known as a Hox paradox (Mann, Lelli and Joshi, 2009). 
One layer of this paradox is due to the limited knowledge of the HOX-DNA binding 
mechanism. So far, the best known HOX cofactors are proteins from the TALE family. TALE 
proteins bind the HOX-TFs on either side of the Homeodomain and change the specificity of 
HOX-DNA contact (Merabet and Mann, 2016). Several large scale in vitro studies have been 
conducted in the past ten years attempting to decipher HOX-DNA binding in different animals 
(M F Berger et al., 2008; Jolma et al., 2013). However, due to the large-scale approach, these 
studies mainly focused on Homeodomain-DNA binding, therefore providing a high affinity 
monomer-like binding motif.  This posed a difficulty, when interpreting HOX binding, since it is 
known that they rarely bind as monomers. Later, Slattery et al. (2011) and Jolma et al. (2015) 
expanded their experimental design to study HOX-cofactor specificity as well. While these 
experiments provided an invaluable source of HOX binding data, they were conducted in vitro 
and with a narrow selection of cofactors. In comparison, this study for the first time provided 
evidence of in vivo vertebrate HOX binding. Therefore, it was imperative to compare the 
discovered HOX motifs with known Homeodomain and HOX motifs.  
Primary motifs identified here show striking discrepancy from either Homeodomain-DNA or 
monomer HOX-DNA binding ( Berger et al. 2008; Jolma et al. 2013). Profound differences in 
motifs are likely due to the presence of full-length proteins and, appropriate cofactors, co-
repressors, and co-activators. More specifically, HOXD11 motif discovered here exhibited 
notable changes in comparison to HOXD11-Homeodomain-DNA binding preference (M F 
Berger et al., 2008; Jolma et al., 2013). HOXD11 motif identified here looks remarkably similar to 
HOXA10-PBX4 dimer binding motif, demonstrating that there are specific changes induced by 
TALE proteins, as captured by this de novo motif analysis (Jolma et al., 2015). Furthermore, 
HOXD11 example indicates that changes in primary HOX motif as defined in this study are 
likely due to cofactors altering HOX binding site affinity.  
However, the investigation of HOX binding also demonstrated that motif change between in vitro 
and in vivo studies is not universal to all HOX-TFs. Specifically; the PG13 group appears to have 
largely unchanged monomer-like motifs enriched in their data, indicating that they might be less 
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reliant on TALE, or other cofactors. Furthermore, in line with other studies, the HOXA13 and 
HOXD13 had both their own, and each other’s motifs enriched, suggesting they can bind DNA 
through both motifs (Zhang et al., 2011; Turner et al., 2014). These results clearly suggest that 
HOX-DNA binding specificities rely on cofactors for indirect but also for direct binding.  
5.2.4 Indirect HOX Binding Sites  
De novo motif analysis aimed at investigation of indirect binding uncovered three motifs of 
putative HOX cofactors: AP1, “Unmatched”, and CTCF.  
“Unmatched” - a Speculative HOXA13 Cofactor 
“Unmatched” motif is a CG rich motif absent from public database. It was centrally enriched and 
abundant in HOXA13 peaks, indicating it could be a potential tethering factor specific for 
HOXA13. However, due to the inability to match this motif with one protein, it is challenging to 
speculate on any possible role this factor could play for HOXA13-DNA binding. 
AP1 - a General Cofactor 
Activating Protein 1 (AP1) is a transcription factor involved in gene activation. It binds the DNA 
in diverse heterodimers coming from any of the four protein families, cJun, cFos, ATF, or JDP. 
It is linked to a broad range of developmental and differentiation processes, but so far has not 
been linked to any HOX-related process (Hess 2004). Here, secondary de novo motif search 
revealed an AP1 motif, indicating AP1 as a possible HOX cofactor. Furthermore, transcriptomic 
analysis demonstrated a high upregulation of FOS and JUN suggesting a cross-regulatory 
mechanism. Finally, this motif has also been identified as a cofactor of many other TFs, such as 
MSX2, RUNX2, and HOXD13R298Q suggesting that AP1 is frequently used as a transcriptional 
cofactor during developmental processes (Turpaev, 2006; Hein, 2013; Ibrahim, 2014). 
CTCF - a HOX Cofactor 
Unbiased comparison of HOX binding profiles indicated a subdivision into two groups: Group 1 
and Group 2. This subgrouping was in part attributed to abundance of indirect binding, mainly 
through CTCF. So far, no study linked the role of CTCF and HOX-driven transcriptional 
programs.  
CTCF is an insulator protein and, together with Cohesin, partly controls genome architecture and 
enhancer-promoter looping (Dixon et al., 2012; Nora et al., 2012; Sexton et al., 2012; Zuin et al., 
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2013; Sanborn et al., 2015). Furthermore, RAD21 (a Cohesin subunit) was often binding HOX-
CTCF co-occupied sites, indicating that triple (HOX-CTCF-RAD21) sites could collectively act 
in local genome organization, either through insulation, initiation, or stabilization of specific 
enhancer-promoter contacts (Figure 5.1). In this way, CTCF and Cohesin could help secure 
stable, tissue specific expression through local genome architecture (Faure et al., 2012; 
Merkenschlager and Odom, 2013; Ing-Simmons et al., 2015). Finally, three possibilities do not 
exclude one another and are all likely mechanisms of gene regulation on a subset of HOX target 
genes.  
These conclusions are in agreement with Beccari et al. (2016), where HOXA13/HOXD13 loss-
of-function mice are unable to switch from early to late Hoxd regulation and as a consequence, 
they have deformed autopod. This deformation is accompanied by an abnormal change in 
H3K27Ac and H3K27me3 over the HoxD locus, indicating that in this case, HOX13 proteins 
are essential for the local micro-architecture and chromatin remodeling. Furthermore, Sheth et al. 
(2016) used the same  HOXA13/HOXD13 loss-of-function mutant mouse and performed 
H3K27me3 and H3K27Ac ChIP-seq. They found changes in H3K27me3 and H3K27Ac profiles 
genome-wide accompanied with transcriptional changes. Results from Beccari et al. (2016), Sheth 
et al. (2016), and from this study support the theory, where HOX-TFs play a vital role in the 
rewiring of local HOX-responsive genome architecture and functional chromatin which in turn 
instigates transcriptional changes.  
However, it is still unclear what the exact mechanism for such micro-architecture establishment 
is. A recent study in Drosophila hinted, there could be a link between developmental TFs and 
CTCF co-binding and signalling pathways (Van Bortle et al., 2015). Van Bortle et al. (2015) 
demonstrated that SMAD TFs - effectors of the TGF-β/BMP signalling pathway -bind on a 
subset of CTCF sites, within TADs, only upon exposure to BMP signaling. Protein-protein 
interactions fully drive this SMAD-CTCF co-binding, and upon depletion of CTCF, SMADs 
cannot bind these genomic positions anymore. Interestingly, HOX-TFs are known to co-bind 
with SMAD proteins, further indicating HOX-CTCF co-binding could be a mechanism of gene 
regulation for a subset of HOX targets (Figure 5.1) (Williams et al. 2005). 
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5.3 HOX Induced Restructuring of Functional Chromatin at 
CTCF sites 
Investigation of functional chromatin in HOXA10 and HOXD13 expressing chMM culture 
demonstrated a gain of H3K27me3, but not H3K4me3 mark around the CTCF binding sites in 
these cultures.  
Narendra et al. (2015) examined the CTCF-induced blockage of H3K4me3 spreading at the 
HoxA cluster. Indeed, when CTCF sites were deleted, H3K4me3 would spread outside the 
normally CTCF bound sites. Given the absence of a genome-wide change of H3K4me3 at CTCF 
sites in HOXA10 and HOXD13 expressing cultures, it is likely that the effect observed by 
Narendra et al. (2015) is a local feature.  
 
Figure 5.1 Schematic summary of different possibilities of HOX binding events in the 
genome. 
Active gene A: HOX-TFs bind on the CRE-A1 and CRE-A2 and contact CTCF to instigate looping between 
enhancers and promoter of gene A. At the same time this co-binding insulates Inactive gene X from its own 
CREs, CRE-X1 and CRE-X2. Active gene B: HOX-TFs bind CRE-B1 either as monomer (right) or, co-bind 
with TALE proteins (left) to activate gene B. Active gene C: HOX-TFs either co-bind with CTCF (right) or 
CTCF tethers HOX proteins to the DNA (left) on proximal CREs to activate gene C. Inactive gene Y: HOX-
TFs either co-bind with or, are tethered by an unknown cofactor to the proximal CREs of gene Y, thereby 
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On the other hand, Cuddapah et al. (2009) study focused on the breadth of H3K27me3 mark 
adjacent to CTCF sites. They noticed that on a genome-wide scale, CTCF demarcates active and 
repressive domains. Interestingly, in this study, upon HOX overexpression there is a slight gain 
of H3K27me3 mark at CTCF sites. Here, chromatin remodeling is found at many active 
promoters belonging to genes involved in metabolic processes, specifically DNA and RNA 
editing and DNA replication. Therefore, it is not trivial to interpret these findings as regulation of 
metabolic processes might be linked either to global transcriptional regulation or various 
homeostatic process. 
5.4 HOXA10 Deletion Construct Instability 
HOXA10 protein interacts with the CTCF. However, due to the likely protein instability, it is 
unclear what the exact interaction domain is. PLA assay suggested possiblity that HOXA10 and 
CTCF bind indirectly. Indeed, in the light of HOX non-canonical (cofactor influenced and 
tethered) binding strategies, discussed above, it is likely that HOX could be found in a larger 
complex, perhaps with SMADs and CTCF, as discussed in the Chapter 5.2.3 (Williams, 
Williams, Heaton, et al., 2005; Mann, Lelli and Joshi, 2009).  
5.5 Outlook 
This is the first study of HOX binding in vivo. Interestingly, the main conclusions both confirm 
earlier HOX binding investigations and offer a new perspective on the non-canonical HOX 
binding sites. HOX-TFs are often bound with cofactors, which alter their sequence affinity. 
Furthermore, an abundance of HOX binding is attributed to tethering events, which are linked to 
CTCF and Cohesin. This finding suggests that HOX proteins likely play a role in local genome 
architecture establishment/management. 
It will be very exciting to investigate these sites in more detail, discover mechanistic properties of 
these binding events, and their functional importance. One possibility of studying this would be 
by the targeted disruption of CTCF binding motifs underlying co-bound sites and investigation 
of subsequent (in)ability of HOX-TF to bind to these positions, as well as functional outcome of 
such mutations. Furthermore, to investigate the local genomic restructuring, it would be ideal to 
obtain structural 3D chromatin data from wild-type and CTCF mutated motifs and assess 
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eventual contact rewiring. Lastly, it would be necessary to shed light on the function of these 
perturbations and thereby, quantify the effect on HOX target gene expression.  
The precise mechanistic and functional delineation of HOX-CTCF co-binding could have far 
reaching implications as it would describe a genuinely novel mechanism for developmental TF 
target regulation. 
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6  Appendix 
 
 
 
 
 
Appendix 1 Summarized Irreproducibility Discovery Rate (IDR) analysis for all the HOX ChIP-
seq data. 
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Appendix 2 All discovered secondary motifs in the HOX ChIP-seq data. 
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Appendix 3 AP1 Centrimo analysis for all the HOX data. 
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Appendix 4 “Unmatched” Centrimo analysis for all the HOX data. 
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Appendix 5 Quality control and IDR analysis for 3xFLAG-tag CTCF ChIP-seq. 
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Appendix 6 Quality control and IDR analysis for RAD21 ChIP-seq. 
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Appendix 8 seqMINER analysis of the H3K27me3 and H3K4me1 binding in the vicinity of  
HOXA10 and HOXD13 peaks in non-infected chMM. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix 7 Proportion of HOX-CTCF-RAD21 co-bound genomic sites expressed as a 
percentage of the RAD21 or CTCF binding sites. 
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Appendix 9 Genomic location of the HOX-CTCF co-bound sites. 
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